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 The Wild-type p53-induced phosphatase 1 (Wip1) is an oncogenic protein, which 
belongs to the protein phosphatase type 2C family. Wip1 plays important roles in 
regulating DNA damage-induced cell cycle checkpoints. The involvement of Wip1 in 
DNA damage pathway confers its oncogenic properities. However, it is still obscure if 
Wip1 has any function in regulating other facets of tumourigenesis such as apoptosis. 
Therefore, one important aim of this study is to investigate the roles of Wip1 in 
regulating apoptosis. We immortalized the mouse embryonic fibroblasts derived from 
wild-type and Wip1-/- mice with SV40 large T antigen. The elimination of Wip1 
causes higher apoptotic responses upon DNA damage, oxidative stress and ribotoxic 
stress. In Wip1-/- MEFs, we observed higher activities of both p38-ATF2 and 
JNK-c-Jun signaling. In agreement with the higher activity of JNK-c-Jun signaling in 
stress-stimulated Wip1-/- MEFs, FasL transcription is also induced more significantly 
than that in wild-type MEFs, contributing to higher susceptibility to apoptosis. Not 
only normal cells but also cancer cells are sensitized to stress-induced apoptosis in the 
absence of Wip1. Inhibition of both p38 and JNK signaling successfully rescues 
stress-induced apoptosis in Wip1-/- MEFs. Moreover, the phosphorylation and 
activation of MKK4, but not MKK7 is differentially regulated between wild-type and 
Wip1-/- MEFs. In vitro phosphatase assay further indicated that Wip1 preferentially 
dephosphorylates Thr261 residue, but not Ser257 residue of MKK4. Thus, Wip1 
plays multiple roles in regulating apoptosis in response to a variety of environmental 
stresses.  
xi 
 The second part of my study was to investigate how Wip1 is regulated in response 
to UV-induced DNA damage. In MCF-7 cells, Wip1 protein level is induced upon low 
doses of UV radiation accompanied with cell cycle checkpoints. However, Wip1 
protein level is suppressed upon high doses of UV radiation in parallel with apoptosis. 
Moreover, the high-dose UV-mediated decrease of Wip1 protein is not a consequence 
of apoptosis. In response to low doses of UV radiation, Wip1 protein is 
transcriptionally induced in a p53-dependent manner. In response to high doses of UV 
radiation, Wip1 protein level is suppressed by both transcriptional and 
post-translational machineries in a p53-independent manner. Our current results 
suggest that Wip1 protein is regulated by the proteasome-mediated degradation. 
However, further experiments need to be done in order to understand whether Wip1 is 
directly degraded through the ubituiqin-proeasome-mediated pathway. We speculate 
that the protein level of Wip1 might act as a mediator of the cell fate in response to UV 
radiation. Higher protein level of Wip1 upon UV radiation may lead to cell cycle 
checkpoints, while lower protein level of Wip1 is possibly related to apoptosis. It is 
not known yet what determines the fate of Wip1 protein upon different doses of UV 
radiation. These results indicate complex regulatory mechanisms of Wip1 protein in 
DNA damage signaling. Further studies are required to promote our understanding of 
the Wip1 function in tumourigenesis. 
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Chapter 1 Introduction 
1.1 The type 2C protein phosphatases 
1.1.1 Phosphorylation regulation of proteins 
 Protein phosphorylation is a reversible post-transcriptional regulatory 
mechanism that occurs in both prokaryotic and eukaryotic organisms (Cozzone, 1988; 
Barford et al., 1998). The phosphorylation status of protein is tightly regulated by 
protein kinases and phosphatases. Kinase is a type of enzyme that transfers phosphate 
groups from high-energy donors to specific substrates (Burnett and Kennedy, 1954). 
Whereas, a phosphatase is an enzyme that removes a phosphate group from its 
substrate by hydrolyzing phosphoric acid monoesters into a molecule with a free 
hydroxyl group and a phosphate ion (Barford et al., 1998). In eukaryotic proteins, 
phosphorylation occurs on serine, threonine and tyrosine residues (Barford et al., 
1998; Chang and Stewart, 1998). In prokaryotic proteins, phosphorylation occurs on 
histidine, arginine and lysine residues (Cozzone, 1988; Stock et al., 1989). In 2002, 
the kinome of human had been identified with 518 kinases (Manning et al., 2002). The 
knowledge of phosphatases develops with a relatively slower pace. Higher eukaryotes 
contain 100-200 genes that encode protein phosphatases (Bollen and Beullens, 2002). 
Based on the substrate specificity and the conservation of their catalytic domains, 
these enzymes are classified into four families (PTP, PPM, PPP and FCP/SCP) 
(Barford et al., 1998; Cho et al., 1999). The PTP family conmprises the protein 
tyrosine phosphatases and the ‘dual-specific’ protein phosphatases, which 
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dephosphorylate phosphor-serine/threonine as well as phosphor-tyrosine residues 
(Barford et al., 1998). All members of the PPM, PPP and FCP families are protein 
serine/threonine phosphatases (Gallego and Virshup, 2005).  
1.1.2 Serine/Threonine phosphatases 
Reversible post-transriptional protein serine/threonine phosphorylation regulates 
virtually every signaling pathway in the eukaryotic cell. Protein serine/threonine 
phosphatases control key biological pathways including early embryonic 
development, cell proliferation, cell death, DNA damage response, and cancer (Bollen 
and Beullens, 2002; Gallego and Virshup, 2005). Based on substrate specificity, the 
serine/threonine phosphatases are divided into three families: PPM, PPP, FCP/SCP 
(Gallego and Virshup, 2005). The PPM family, including PPM1/PP2C, consists of 
metal-ion-dependent monomeric enzymes (Honkanen and Golden, 2002). Unlike 
PPM family, members of PPP phosphatases, such as PP1 and PP2A, are oligomeric 
holo-enzymes, containing catalytic subunits and regulatory domains (Bollen, 2001; 
Janssens and Goris, 2001). The FCP/SCP phosphatase FCP1 specifically 
dephosphorylates the CTD domain of RNA polymerase II (Cho et al., 1999). 
1.1.3 Biological function of type 2C protein phosphatases 
 A number of interesting features, phenotypes and potential clinical applications 
have been ascribed to the type 2C family of protein phosphatases. A recent review 
showed that 16 different PP2C genes have been identified in the human genome, 
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encoding for at least 22 different PP2C isozymes (Lammers and Lavi, 2007). In 
eukaryotes, PP2Cs have been predominantly linked to cell growth and cellular stress 
signaling (Lammers and Lavi, 2007). In Arabidopsis, PP2Cs (such as ABI1 and ABI2) 
act as negative regulators of the ABA signaling pathway, therefore down-regulating 
cellular stress signaling (Schweighofer et al., 2004). The yeast PP2Cs (Ptc1, Ptc2 and 
Ptc3) control the basal and maximal activation of yeast MAPK (HOG1) (Young et al., 
2002). In addition, Ptc2 and Ptc3 also play roles in coordinating cell cycle by 
removing the activating phosphorylation of Cdc28 in yeast (Cheng et al., 1999). In 
mammals, PP2Cs play more diverse roles with their main involvements in stress 
signaling and cell growth. The best characterized PP2Cα serves as a negative 
regulator of JNK and p38 signaling by dephosphorylating MKK4, MKK7, MKK3b, 
MKK6b (Hanada et al., 1998). PP2Cα even interacts with p38 and dephosphorylates 
its conserved Thr180 residue (Takekawa et al., 1998). Over-expression of PP2Cα 
results in G2/M cell cycle arrest and apoptosis (Ofek et al., 2003). PP2Cβ displays 
similar function as PP2Cα in regulating JNK/p38 stress MAPKs. PP2Cβ1 
over-expression leads to reductions in the levels of phosphorylated MKK3b and 
MKK6b (Hanada et al., 1998). In addition, PP2Cβ1 over-expression reduces the 
phosphosrylation and activity of MKK4 and MKK7 (Hanada et al., 1998). 
Collectively, many observations demonstrate that the type 2C protein phosphatases 
are broadly involved in regulating cell growth and cellular stress signaling.  
Introduction 
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1.2 The function of Wip1 
1.2.1 The characterization of Wip1 
 In 1997, PP2Cδ was initially identified by Fiscella and colleagues as Wip1, 
wild-type p53-induced phosphatase 1, in a screening for ionizing radiation-induced 
transcripts in Burkitt lymphoma cells that carry a wild-type p53 (Fiscella et al., 1997). 
The expression of Wip1 was found to be up-regulated in a wild-type p53-dependent 
manner in response to ionizing radiation (Fiscella et al., 1997; Takekawa et al., 2000). 
Wip1 is encoded by the Ppm1d (protein phosphatase magnesium-dependent 1 delta) 
gene, which maps to chromosome 17q22-q23 (Fiscella et al., 1997; Bulavin et al., 
2002; Choi et al., 2002; Li et al., 2002). The open reading frame of Wip1 protein is 
comprised of 605 amino acids (Fiscella et al., 1997). Sequence analysis with other 
PP2C family members predicts that Wip1 belongs to type 2C protein phosphatases 
(Fiscella et al., 1997). The PP2C-like phosphatase domain is located in the N-terminal 
of Wip1 (Fiscella et al., 1997; Choi et al., 2000). Similar to other PP2C family 
members, the phosphatase activity of Wip1 is dependent on Mg2+, and is insensitive to 
okadaic acid-mediated inhibition (Fiscella et al., 1997). It was found that Wip1 is 
localized exclusively to the nucleus in Saos-2 cells (Fiscella et al., 1997). The ectopic 
expression of Wip1 leads to suppression of colony formation (Fiscella et al., 1997). 
Subsequent investigations gradually unravel the important function of Wip1 in 
controlling cell growth, cellular stress signaling and tumor formation.  
 The biological functions of Wip1 have been investigated using wild-type and 
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Wip1-deficient mice. Choi et al. reported that Ppm1d mRNA is ubiquitously 
expressed, with particular high levels in the post-meiotic round spermatid 
compartment of the testes (Choi et al., 2000; Choi et al., 2002). The mouse model 
studies also revealed that Wip1 is induced by IR in a wild-type p53-dependent manner 
in multiple tissues (Choi et al., 2002). Wip1-deficient mice exhibit normal embryonic 
development, but show a variety of postnatal abnormalities, including male runting, 
reduced male longevity, male reproductive organ atrophy, and reduced male fertility 
(Choi et al., 2002). Mice lacking Wip1 also display reduced T- and B-cell function 
accompanied with increased susceptibility to pathogens (Choi et al., 2002). 
Wip1-deficient MEFs have decreased proliferation rates and are compromised in 
entering mitosis (Choi et al., 2002). The mouse model studies indicate that Wip1 plays 
important roles in spermatogenesis, lymphoid cell function and cell cycle regulation.  
1.2.2 The substrates of Wip1 
1.2.2.1 p38/p53 
 The first report describing an involvement of PP2Cδ in regulating cell growth and 
cellular stress signaling was provided by Takekawa and colleagues. They observed 
that the expression of Ppm1d gene is up-regulated in response to IR- or UV-induced 
DNA damage stress, oxidative stress and ribotoxic stress (Takekawa et al., 2000). 
Moreover, they found that Wip1 associates with p38 and dephosphorylates p38 on its 
conserved Thr180 residue, which is essential for the kinase activity of p38 (Takekawa 
et al., 2000). However, Wip1 does not show any effect on other MAPKs, such as 
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ERK2 and JNK1 (Takekawa et al., 2000). As a consequence, Wip1 indirectly 
attenuates the stress-induced p38-mediated phosphorylation of p53 on Ser33 and 
Ser46 residues (Bulavin et al., 1999). Taking into account that p53 induces Wip1 
expression; Wip1 forms a negative feed back loop with p53 and p38. In response to 
UV or IR, p53 induces the expression Wip1, which in turn dephosphorylates and 
inhibits the kinase activity of p38, resulting in reduced phosphorylation and activation 
of p53. Over-expression of Wip1 reduces p38 kinase activity and p53 transcription 
activity, and consequently suppresses UV-induced apoptosis (Takekawa et al., 2000). 
This special characteristic of Wip1 suggests that Wip1 may harbor oncogenic 
properties.  
 In agreement with the biochemical studies, Wip1-/- MEFs display higher 
expression levels of phospho-p38. A considerable higher phosphorylation of p53 at 
Ser15 residue is also observed in Wip1-/- MEFs (Lu et al., 2005). Lu et al. reported 
later that Wip1 directly dephosphorylates Ser15 residue, but not Ser46 residue in p53 
(Lu et al., 2005). Over-expression of Wip1 suppresses the phosphorylation of p53 on 
Ser15 site upon UV radiation (Lu et al., 2005). Wip1 regulates DNA damage-induced 
intra-S-phase and G2/M checkpoints at least partly by mediating the phosphorylation 
of p53.  
1.2.2.2 UNG2/Chk1/Chk2 
 Collective studies have gradually identified Wip1 as a homeostatic coordinator of 
cell cycle checkpoints. DNA excision repair pathways include nucleotide excision 
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repair (NER) and base excision repair (BER) (Hakem, 2008). Uracil DNA 
glycosylases are a type of enzymes, which remove uracil from mammalian cell DNA 
(Lu et al., 2004). UNG2 is the dominant enzyme for uracil removal in nuclear DNA. 
In 2004, UNG2 was identified as a novel binding partner and substrate of Wip1. 
UNG2 can be phosphorylated on multiple residues after UV exposure (Kavli et al., 
2002). In response to UV radiation, Wip1 dephosphorylates UNG at Thr6 residue in 
vivo (Lu et al., 2004). This dephosphorylation and inhibition of UNG2 suppress 
uracil-associated BER activity. More importantly, the Wip1-mediated UV-induced 
suppression of BER is independent of p53, suggesting Wip1 dephosphorylation and 
inhibition of UNG2 as the major cause of the hampered BER (Lu et al., 2004).  
 The roles of Wip1 in DNA damage-mediated stress pathway have been unraveled 
gradually. In 2005, one year after the identification of UNG2 as a Wip1 substrate, the 
same group discovered another Wip1 substrate, Chk1. Wip1 interactes with Chk1 via 
the N-terminal of its PP2C-like domain (Lu et al., 2005). UV or IR induces 
phosphorylation of Chk1 on its Ser317 and Ser345 residues (Sancar et al., 2004). 
Wip1 selectively dephosphorylates Chk1 on its Ser345 residue, and such 
dephosphorylation inhibites Chk1 kinase activity (Lu et al., 2005). In response to 
DNA damage, Wip1 dephosphorylates and inactivates Chk1, leading to suppression 
of the intra-S-phase and G2/M checkpoints (Lu et al., 2005). Thus far, Wip1 has been 
identified as a homeostatic regulator of cell cycle checkpoints. Once the DNA damage 
is repaired, certain mechanism should exist to return the arrested cells to a 
homeostatic status. Wip1 may be involved in this kind of homeostatic regulation.  
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 In 2006, Chk2 appeared in the substrate list of Wip1. Similar to Chk1, Chk2 plays 
a crucial role in DNA damage-induced cell cycle checkpoint regulation (Shiloh, 2001). 
Wip1 associates with Chk2 in the nuclei and dephoephorylates the DNA 
damage-induced phosphorylation of Thr68 residue in Chk2 (Fujimoto et al., 2006). In 
the absence of Wip1, IR stress induces abnormally sustained Thr68 phosphorylation 
and kinase activity of Chk2 (Fujimoto et al., 2006). On the contrary, over-expression 
of Wip1 antagonizes Chk2-dependent apoptosis upon IR stress (Fujimoto et al., 
2006).  
1.2.2.3 ATM 
 Upon DNA damage, the PI3-like kinases ATM (ataxia-telangiectasia mutated) 
and ATR (ataxia-telangiectasia and Rad3-related) phosphorylate cellular target 
proteins that subsequently activate DNA repair pathways and cell cycle checkpoints 
in order to maintain genomic integrity (Shiloh, 2001; Harper and Elledge, 2007). 
ATM and ATR phosphorylate a group of downstream proteins including Chk1 and 
Chk2, p53, p38 and so on (Kurz and Lees-Miller, 2004; Harper and Elledge, 2007). 
Interestingly, these four above mentioned proteins are all Wip1 substrates. In 2006, 
Shreeram et al. characterized Wip1 as an essential component of the ATM-dependent 
signaling pathway. In Wip1-deficient cells, the ATM-p53-dependent signaling 
pathway has higher activity than that in wild-type cells (Shreeram et al., 2006b). Wip1 
forms a complex with ATM in vivo and dephosphorylates ATM on its conserved 
Ser1981 residue, the phosphorylation of which is induced by IR (Shreeram et al., 
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2006b). Therefore, Wip1 plays important roles in resetting ATM phosphorylation into 
basal level after the DNA damage has been repaired. 
1.2.2.4 Mdm2 
 Wip1 is induced by DNA damage in a p53-dependent manner, and inhibits 
UV-induced p38 activation, thereby indirectly inhibiting the phosphorylation of p53. 
As a result, Wip1 forms a negative feedback loop with p53 and p38. Although Wip1 
regulates p53 activity via a different mechanism from Mdm2, the resultant effect is 
similar to that caused by Mdm2 (Bond et al., 2005). Following DNA damage, both 
p53 and Mdm2 are phosphorylated by ATM and other kinases so as to prevent Mdm2 
from interacting with p53, ensuring p53 stabilization (Canman et al., 1998; Maya et 
al., 2001). ATM phosphorylates p53 on Ser15 residue, and targets Mdm2 for 
phosporylation on Ser395 residue (Canman et al., 1998; Maya et al., 2001). In 2007, 
Lu et al. reported that Wip1 interactes with Mdm2 and dephosphorylates it at Ser395 
residue (Lu et al., 2007). By dephosphorylating Mdm2, Wip1 enhances p53-Mdm2 
interaction and augmentes Mdm2 stability by suppressing Mdm2 self-interaction and 
autoubiquitination (Lu et al., 2007). Consequently, Wip1 destabilizes p53 by 
enhancing its ubiquitination, and inhibites p53 transcription activity upon DNA 
damage (Lu et al., 2007). Moreover, the dephosphorylation regulation of Wip1 on 
Mdm2 is independent of ATM (Shreeram et al., 2006b; Lu et al., 2007). In the early 
stage after DNA damage, p53 is stabilized as a result of p53 and Mdm2 
phosphorylation by ATM. Cell cycle checkpoints and DNA repair occur in this stage. 
Introduction 
10 
p53 transactivates a number of genes including p21, Mdm2, Ppm1d and so on. At later 
time points after DNA damage insult, Wip1 dephosphorylates p53 and Mdm2, 
initiates ubiquitination-mediated proteolysis of p53, and relievs cells from cell cycle 
checkpoints.  
1.2.2.5 NF-κB 
 Wip1-deficient mice display enhanced inflammation, indicating Wip1 may be an 
important regulator of inflammatory responses in vivo (Choi et al., 2002). The 
transcription factor NF-κB controls a plethora of genes in response to a large number 
of physiological stimuli, especially those induced by inflammatory cytokines. IκB 
proteins inhibit NF-κB function by preventing its binding to DNA. IKK1 and IKK2 
phopshorylate IκBs, thus mark IκB for degradation and allow NF-κB to relocate into 
nucleus and bind to DNA (Karin and Ben-Neriah, 2000; Hayden and Ghosh, 2008). 
Compared to the processes of NF-κB activation, the processes involved in the 
termination of NF-κB are not well understood. It has been establisehd that 
phosphorylation of Ser536 in the p65 subunit is essential for the transactivation 
function of p65, because it is required for recruitment of the transcriptional 
co-activator p300 (Hayden and Ghosh, 2008). It was recently reported that Wip1 
dephosphorylates Ser536 residue in p65 subunit of NF-κB both in vivo and in vitro 
(Chew et al., 2009). However, Wip1 displays tiny effect on other phospho-residues of 
NF-κB, such as Ser468, Thr254, Ser276 and Ser311 (Chew et al., 2009). By 
dephosphorylating Ser536 residue of NF-κB, Wip1 reduces p65 interaction with the 
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transcriptional co-activator p300, and hence transcription of its target genes (Chew et 
al., 2009). Therefore, Wip1 negatively modulates TNFα-induced NF-κB 
transcriptional activity on certain promoters, including TNFα itself. Consistently, the 
Wip1-deficient mice show increased levels of TNFα mRNA, and enhanced 
inflammation of many organs such as spleen and lung. 
1.2.2.6 Substrate specificity of Wip1 
 Investigating Wip1 substrate specificity helps to predict other physiological 
substrates and to design specific inhibitors. The substrate specificity of Wip1 was first 
studied by the kinetic analysis using recombinant Wip1 phosphatase catalytic domain 
(rWip1), because the activity of the catalytic domain is comparable with that of 
full-length Wip1 (Yamaguchi et al., 2005). In p38 and UNG2, Wip1 recognizes and 
dephosphorylates the pTGpY and pTLpY motifs, respectively. The substrate 
specificity constant for a diphosphorylated peptide with a pTXpY sequence is 6 to 
8-fold higher than that of a monophosphorylated peptide with a pTXY sequence 
(Yamaguchi et al., 2005). In addition, rWip1 recognizes substrates of different chain 
lengths with at least five residues in length and containing a pTXpY sequence. The X 
residue in the pTXpY sequence affects the affinity between the substrates and rWip1 
(Yamaguchi et al., 2005). The authors proposed that the optimal substrate sequence 
for Wip1 may be X-1-pT-X+1-pY-X+3. X-1, X+1 and X+3 represent any amino acid, any 
aliphatic amino acid, and any amino acid except proline, respectively (Yamaguchi et 
al., 2005). However, peptides with a pSXpY sequence inhibit Wip1 phosphotase 
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activity (Yamaguchi et al., 2005).  
 The understanding of Wip1 substrate specificity progresses when more substrates 
of Wip1 have been identified. Inspired by the discovery of ATM as a physiological 
substrate of Wip1, the same group identified a new optimal substrate motif of 
recombinant human Wip1 catalytic domain (rWip1) (Shreeram et al., 2006b; 
Yamaguchi et al., 2007). From the ATM (1981pS) peptide substitution analysis, motif 
(D/E)-(D/E)-X-1-p(S/T)-Q-X+2 was identified as rWip1 substrate. X-1 and X+2 
represent any amino acid and any amino acid except basic amino acids and proline, 
respectively. The Gln at position +1 in the p(S/T)Q sequence is an essential residue for 
Wip1 recognition (Yamaguchi et al., 2007). Acidic residues surrounding the p(S/T)Q 
sequence have a positive influence, while basic residues have a negative influence on 
substrate recognition (Yamaguchi et al., 2007). Based on this information, several 
putative substrates of Wip1 have been proposed including SMC1A Ser957, Hdm2 
Ser395 and ATR Ser1876 (Yamaguchi et al., 2007). Interestingly, both the pTXpY and 
the p(S/T)Q motif bind to the catalytic site of Wip1 in similar orientations and 
positions.  
 Based on the rationale of these two substrate motifs, several specific inhibitors 
have been developed, including those containing p38(pThr180 pTyr182) sequence 
and an F2Pab-substituted p53(pSer15) peptide (Yamaguchi et al., 2006). In addition, 
thioether cyclic phospho-peptides with a pSIpY sequence show high inhibitory 
activity toward Wip1 (Yamaguchi et al., 2006). Therefore, nonhydrolyzable 
phospho-serine mimetic-substituted derivatives were developed to selectively inhibit 
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Wip1. Further studies developed a small, drug-like, molecular scaffold based on the 
cyclic peptide c (MpSIpYVA), which is more selective in inhibiting Wip1 activity 
(Bang et al., 2008). On the other hand, chemical inhibitors of Wip1 were also 
identified by high-throughput screening. In 2005, Belova et al. screened a diversity set 
library comprised of 1990 chemical compounds (Developmental Therapeutics 
Program NCI/NIH). The enzyme activity assay using recombinant Wip1 revealed 14 
out of 1990 compounds with a capability to inhibit Wip1 phosphatase activity (Belova 
et al., 2005). In 2008, Rayter and colleagues performed an even larger scale screening 
for the chemical inhibitor of Wip1, and identified and characterized 6 out of 65500 
compounds (Rayter et al., 2008). The studies of Wip1 inhibitors provide potential 
agents as lead compounds for anticancer drug targeting Wip1 phosphatase. 
1.2.3 The Wip1 function in tumourigenesis 
1.2.3.1 The over-expression of Wip1 in cancers 
 Shortly after the characterization of Wip1, it was discovered that Wip1 associates 
tightly with many types of human cancers. In 2002, two groups made the discovery at 
the same time that Ppm1d, the gene encoding Wip1 phosphatase, lies within an 
epicenter of the region at 17q22/23 that is amplified in breast cancer (Bulavin et al., 
2002; Li et al., 2002). Comparative genomic hybridization (CGH) analysis detects 
amplification of 17q22-q24 in 18% of primary breast tumors (Sinclair et al., 2003). 
They proceeded to examine the oncogenic properties of Wip1, and found that 
over-expression of Wip1 attenuates apoptosis induced by serum starvation, and 
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transforms primary cells in cooperation with E1A and Ras (Bulavin et al., 2002). 
Over-expression of Wip1 contributes to tumor formation by inactivation of the p38 
MAPK and subsequent inhibition of p53 (Bulavin et al., 2002). In agreement, the 
amplification of Ppm1d is found in approximately 11% of primary breast tumors, 
most of which harbor wild-type p53 (Bulavin et al., 2002; Li et al., 2002). Moreover, 
siRNA-mediated inhibition of Ppm1d in BT-474, MCF-7 and ZR-75-1 breast cancer 
cell lines harboring amplification of Ppm1d resulted in significantly reduced cell 
proliferation in MCF-7 and ZR-75-1 cells carrying wild-type p53 but not in BT-474 
carrying mutant p53 (Parssinen et al., 2008). Furthermore, silencing of Ppm1d by 
short hairpin RNA resulted in selective loss of viability in tumor cells harboring 
17q23.2 amplification (Han et al., 2009; Natrajan et al., 2009).  
 In neuroblastomas, the amplification of 17q23 was also identified using CGH in 
25 neuroblastomas cell lines (Saito-Ohara et al., 2003). Seven genes are consistently 
over-expressed through increases in regional copy number. Among these genes, 
Ppm1d is the only one showing a significant correlation between higher expression 
and better clinical outcome (Saito-Ohara et al., 2003). Down-regulation of Wip1 
using an antisense oligonucleotide remarkably suppresses the growth of 
neuroblastomas cells, by regulating a process leading to apoptotic cell death 
(Saito-Ohara et al., 2003). Therefore, Ppm1d plays an important role in the 
pathogenesis of neuroblastomas. 
Dosmoplastic medulloblastoma (DMB), a malignant embryonic tumor of the 
cerebellum, mainly occurs in children. Previous studies discovered mutations in genes 
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encoding members of the Sonic Hedgehog pathway in DMB. Array-based CGH 
analysis identified new amplicons in DMB including 9p24 and 17q23 (Ehrbrecht et al., 
2006). Molecular analysis of selected candidate genes within 17q23 revealed that 
DMB tumors have a relative increase of more than 5-fold in gene copy number at 
RPS6KB1 and Ppm1d loci (Ehrbrecht et al., 2006). In medulloblastoma, although 
Tp53 is rarely mutated, accumulating evidence indicates that Tp53 pathways are 
disrupted in this disease. Thus, over-expression of Wip1 may negatively regulate 
p53-mediated pathways, such as apoptosis, in medulloblastoma (Castellino et al., 
2008). 
 In examining the nonrandom chromosomal aberrations in ovarian clear cell 
adenocarcinomas (OCCA), gain of DNA at 17q21-24 was identified, which might be 
responsible for the malignant phenotype and poor prognosis of this disease (Hirasawa 
et al., 2003). Among 15 candidate genes within this region, the expression of Ppm1d 
is remarkably elevated. It was reported recently that Ppm1d amplification is 
significantly correlated with OCCA histology and found in 10% of primary OCCA 
(Hirasawa et al., 2003). Wip1 expression and phosphatase activity are selectively 
required for survival of OCCA cell lines with 17q23.2 amplification (Tan et al., 2009).  
 Recent studies revealed that gain of Ppm1d at 17q23 is also identified in 
pancreatic adenocarcinoma. Ppm1d could be a potential therapeutic target and an 
indicator predicting patient outcome in this disease (Loukopoulos et al., 2007). 
Moreover, the up-regulation of Wip1 was also detected in gastric cancer. In the tumor 
tissues, 74% of 53 gastric cancers have intense Wip1 immunoreactivity and a close 
Introduction 
16 
correlation with both tumor size and Chk2 dephosphorylation (Fuku et al., 2007). 
These results suggest that Wip1 up-regulation in gastric cancers disruptes Chk2 
phosphorylation and subsequent cell cycle checkpoint in G2 phase.  
1.2.3.2 Mouse model studies  
 Most human genes have functional mouse counterparts. The human genome is 
organized in a very similar manner as the mouse genome. The mouse Wip1 comprised 
598 amino acids. Comparison of human and mouse Wip1 protein sequences reveals 
83% overall identity at amino acid level (Choi et al., 2000). Mouse model studies 
provide profound insights into the function of Wip1 in tumourigenesis.  
 In 2004, Bulavin et al. reported that disruption of Ppm1d gene activates the p53 
and p16-p19 pathways through p38 MAPK signaling, and suppresses in vitro 
oncogene-induced transformation of MEFs (Bulavin et al., 2004). The Ppm1d-null 
MEFs have higher protein levels of p53, p16 and p19 than the wild-type MEFs. In 
mammary tissues of Ppm1d-null mice, the p16-pRb pathway is disrupted due to 
activation of p38 (Bulavin et al., 2004). Therefore, Ppm1d-null mice are resistant to 
Erbb2- and Hras1-induced mammary tumor formation. Inhibition of p38 activity in 
Ppm1d-null mice reduces p16 and p19 expression, leading to tumor formation in 
Ppm1d-/- Erbb2 mice (Bulavin et al., 2004; Harrison et al., 2004).  
ATM-dependent pathway is activated in the early process of human 
tumourigenesis and serves as an anticancer barrier that helps to delay or prevent 
cancer. ATM deficiency results in early onset of lymphomas in mice. Shreeram et al. 
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have shown that Wip1 deficiency suppresses Myc-induced lymphomagenesis 
(Shreeram et al., 2006a). Moreover, p38 MAPK is not required to render 
Wip1-deficient mice resistant to Myc-induced lymphomas (Takekawa et al., 2000; 
Shreeram et al., 2006a). Moreover, Wip1 deficiency suppresses Myc-induced 
lymphomagenesis in an ATM/p53-dependent but Arf-independent manner, because 
ATM is critical in the activation of Myc-induced apoptosis (Shreeram et al., 2006a). 
Wip1 deficiency protects mice from oncogene-induced tumourigenesis. On the 
contrary, over-expression of Wip1 accelerates tumor formation in combination with 
other oncogenes. The mouse breast epithelium is prone to cancer when intercrossed 
with transgenics expressing the Erbb2 oncogene. Demidov et al. reported that 
targeted expression of Wip1 to mammary tissue accelerates tumor formation in 
MMTV-Erbb2 transgenic mice (Demidov et al., 2007b). Over-expression of Wip1 
may accelerate tumor formation by enhancing proliferation but not by reducing 
apoptosis in such case. In order to examine the involvement of p38 MAPK in 
Wip1-regulated tumourigenesis, MMTV-Erbb2/PPM1D/MKK6 transgenic mice were 
generated. In agreement with previous studies, MKK6/p38 MAPK signaling pathway 
mitigates the tumor prone-phenotype of MMTV-PPM1D mice by attenuating 
proliferation (Demidov et al., 2007b).  
Recent studies revealed that Wip1 plays an essential role in regulating the 
homeostasis of intestine stem cells. Accumulating evidence supports a role for stem 
cells in tumorigenesis, including colorectal cancer (O'Brien et al., 2007; Ricci-Vitiani 
et al., 2007). Intestine stem cells have evolved protective mechanisms against genetic 
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damage by removing the damaged cells by p53-dependent apoptosis. The ApcMin/+ 
mice is a fine animal model to study colorectal cancer, because several intestinal stem 
cell markers are highly expressed in ApcMin adenomas and carcinomas (Van der Flier 
et al., 2007). Demidov et al. have shown that Wip1 is expressed in intestine stem cells. 
Wip1 deficiency dramatically suppresses polyp formation in the presence of the 
ApcMin mutation, suggesting that Wip1 is critical in regulating ApcMin-driven 
polyposis (Demidov et al., 2007a). In Wip1-deficient mice, increased intestinal stem 
cell apoptosis is observed in a p53-depedent manner. Wip1 deficiency does not affect 
β-catenin signaling or intestinal cell proliferation (Demidov et al., 2007a; Van der 
Flier et al., 2007). Moreover, in Wip1-deficient mice, activation of β-catenin signaling 
pathway triggers efficient apoptosis of intestinal stem cells under conditions in which 
the level of p53 is already enhanced (Demidov et al., 2007a). Therefore, Wip1 
regulates homeostasis of intestinal stem cells, especially in the presence of oncogenes. 
In turn, Wip1 loss suppresses ApcMin-driven polyposis by setting a threshold for 
p53-dependent apoptosis of stem cells, thus preventing their conversion into 
tumor-initiating stem cells.   
1.2.4 The summary of Wip1 function 
 The discovery of Wip1 sheds new light on the delicate regulation of DNA damage 
signaling pathway. Wip1 targets several important mediators of DNA damage 
pathway for dephosphorylation, including p38, p53, Chk1, Chk2, ATM and Mdm2. 
Molecular and genetic studies revealed that the regulation of DNA damage pathway 
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by Wip1 confers its oncogenic characteristics. Many types of cancers harbor 
amplification of Ppm1d gene and over-expression of Wip1 protein. Biochemical 
studies have identified the recognition motifs of Wip1 substrates and several 
inhibitors of Wip1 phosphatase, providing potential therapeutical methods to cure 
cancer. In addition, Wip1 also plays important roles in regulating inflammatory 
response. Therefore, Wip1 phosphatase is involved in different signaling networks of 
mammalian organisms. 
1.3 The function of apoptosis in tumourigenesis 
1.3.1 Apoptosis and necrosis 
 Apoptosis is a highly regulated process of cell deletion and plays a fundamental 
role in maintaining tissue homeostasis in both the developing and the adult organism. 
Moreover, apoptosis is a constitutive suicide program existing in most cells, and can 
be triggered by a variety of extrinsic and intrinsic signals (Gerschenson and Rotello, 
1992; Saikumar et al., 1999). In addition, apoptosis occurs in a well-choreographed 
sequence of morphological events. The dying cell undergoes a series of biochemical 
events that lead to a variety of morphological changes, including changes to the cell 
membrane such as loss of membrane asymmetry and attachment, cell shrinkage, 
chromatin condensation and DNA fragmentation (Wyllie, 1993). Eventually, the cell 
breaks up into membrane-enclosed particles termed apoptotic bodies containing intact 
organelles, as well as portions of the nucleus. These apoptotic bodies are then rapidly 
recognized, ingested, and degraded by phagocytes or neighboring cells (Wyllie, 1993; 
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Saikumar et al., 1999). Typically, apoptosis does not induce inflammation or tissue 
scarring. Therefore, it is involved in normal cell turnover during embryogenesis and 
in adult tissues.  
 Unlike apoptosis, necrosis is a pathological or accidental mode of cell death, 
characterized by irreversible swelling of the cytoplasm and distortion of organelles. 
Eventually, loss of membrane integrity results in cell rupture and release of noxious 
cellular contents (Wyllie, 1993; Saikumar et al., 1998; Saikumar et al., 1999). 
Consequently, contiguous cells are affected, and inflammation develops in the 
surrounding tissues. Necrosis normally occurs when cells are subjected to toxic 
stimuli such as hyperthermia, metabolic poisons and direct cell trauma (Saikumar et 
al., 1999). The ‘decision’ of the cell to die by necrosis or apoptosis is largely 
dependent on the severity of the insult.  
 Other forms of cell death have been reported in recent years, including autophagy 
paraptosis, necroptosis and oncosis (Leist and Jaattela, 2001). However, the 
molecular regulation and significance of these modes of cell death need further 
investigation.  
1.3.2 Molecular mechanisms of apoptosis 
 Fig. 1.1 depicts the three main routes of apoptosis in mammalian cells (Fadeel 
and Orrenius, 2005). The intrinsic, mitochondria-dependent pathway is extensively 
used in response to extracellular cues and internal insults such as DNA damage (Fig. 
1.1A) (Danial and Korsmeyer, 2004). The extrinsic or death receptor-mediated 
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pathway plays a fundamental role in the maintenance of tissue homeostasis, especially 
in the immune system (Fig. 1.1B) (Danial and Korsmeyer, 2004). In addition to the 
two major pathways depending on caspase activation, several other pathways for 
activation of apoptosis in mammalian cells have been described. For example, 
cytotoxic T cells and natural killer cells trigger apoptosis of susceptible target cells 
either through a Fas ligand- or perforin/granzyme B-dependent pathway (Fig. 1.1B) 
(Trapani and Smyth, 2002). This pathway operates mainly in viral defense and 




Figure 1.1 The schematics of mammalian apoptotic pathways. (A) The 
mitochondria-dependent apoptotic machinery in mammalian cells. (B) Death 
receptor- and lytic granules-mediated apoptotic pathways. (This Figure was 
adapted from Fadeel et al. 2005)  
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1.3.3 Biological function of apoptosis 
 Decades of studies have discovered that apoptosis is an essential biological 
process of living organisms. Apoptosis is an integral part of both plant and animal 
tissue development, important for establishment and maintenance of tissue 
architecture. During animal development, numerous structures are firstly formed, and 
then removed by apoptosis. Apoptosis is also involved in a quality-control and repair 
mechanism that contributes to the plasticity during development by compensating for 
many genetic or stochastic developmental errors (Meier et al., 2000).  
 Normal homeostasis of the immune system is controlled by a balance of 
production and death. During an immune response, homeostasis is disturbed when 
antigen-presenting cells become activated and promote the expansion of 
antigen-specific lymphocytes. Shortly after the peak of the response, both 
antigen-presenting cells and lymphocytes are subjected to strictly controlled 
apoptosis, leading to restoration of homeostasis (Opferman and Korsmeyer, 2003; 
Hildeman et al., 2007). Therefore, immune homeostasis is dependent on apoptosis 
induction and the rapid clearance of cell corpses, in peripheral and central lymphoid 
organs (Fadeel and Orrenius, 2005). 
 In human, the balance between mitosis and apoptosis is crucial for maintaining 
the cellular homeostasis (Jacobson et al., 1997). Recent studies suggest that apoptosis 
deregulation contributes to about half of all the major medical illnesses for which 
proper therapy or prevention is currently lacking (Fadeel and Orrenius, 2005). For 
instance, autoimmune disease may arise from defective elimination of autoreactive T 
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or B cells, leading to tissue destruction (Lauber et al., 2004). Apoptosis also has a 
potential role in neurodegenerative diseases. Abnormality in caspase-driven apoptosis 
causes failures in brain development (Ranger et al., 2001).  
 Among all the diseases, in which defective apoptosis may share responsibility, 
cancer is the most prominent one. Cancer is a genetic disease, and tumors are 
developed via a process, in which a succession of genetic changes, each conferring 
certain type of growth advantage, leads to the progressive conversion of normal 
human cells to cancers (Hanahan and Weinberg, 2000). Most of human tumors share 
several common physiological characteristics including, self-sufficiency in growth 
signals, insensitivity to growth-inhibitory signals, apoptosis resistance, limit less 
replicative potential, sustained angiogenesis, and tissue invasion and metastasis 
(Hanahan and Weinberg, 2000). Apoptosis resistance may contribute not only to 
tumourigenesis, but also be involved in resistance of cancer cells to conventional 
chemotherapeutic drugs and irradiation (Fulda and Debatin, 2004).      
1.3.4 The involvement of apoptosis in tumourigenesis 
 In recent years, basic cancer research has produced remarkable advances, one of 
which is the realization that apoptosis and the genes control it have a profound effect 
on the malignant phenotype. As the first tumor suppressor gene linked to apoptosis, 
Tp53 mutations occur in the majority of human tumors and are often associated with 
advanced tumor stage and poor patient prognosis (Lowe and Lin, 2000). These 
mutations abolish the ability of p53 to activate downstream apoptotic proteins in 
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response to genotoxic stress. Among these p53 downstream targets, the BH3-only 
proteins, including PUMA, NOXA and BID appear to play a prominent and direct role 
(Nakano and Vousden, 2001; Yu and Zhang, 2004). Apaf-1 and caspase-9 both serve 
as downstream effectors of p53-dependent apoptosis, and the disruption of these key 
players of intrinsic apoptosis signaling facilitates oncogenic transformation and tumor 
development in mice (Soengas et al., 1999). Moreover, p53 itself was proposed to 
function in a manner similar to the BH3-only proteins to trigger a 
transcription-independent activation of BAX, thereby engaging the intrinsic apoptotic 
program (Chipuk et al., 2004). Recent studies have described a novel family of 
proteins termed apoptosis-stimulating protein of p53 (ASPP), which are able to 
interact with p53 and specifically enhance p53-induced apoptosis but not cell cycle 
arrest (Bergamaschi et al., 2003). The inhibitory member of ASPP (iASPP) acts as an 
inhibitor of p53, and is up-regulated in human breast cancers expressing wild-type 
p53 and normal levels of ASPP (Bergamaschi et al., 2003).  
Deregulation of members of the BCL-2 family proteins is also common in human 
cancers (Kitada et al., 2002). The BCL-2 gene at 18q21 is involved in chromosomal 
translocations with the immunoglobulin heavy chain (IgH) locus at 14q32 in over half 
of all non-Hodgkin’s lymphomas (NHL), including 90% follicular B-cell lymphomas 
and approximately one-third of diffuse large cell lymphomas (Weiss et al., 1987). 
Moreover, elevations in BCL-2 protein levels are commonly found in a variety of 
hematopoietic malignancies (Gascoyne et al., 1997). Conversely, BAX is a death 
promoter that is inactivated in certain types of colon cancers and in hematopoietic 
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malignancies (Miyashita and Reed, 1995; Lowe and Lin, 2000).  
Several TNF family cytokine receptors transduce apoptosis signals, including 
TNF-R1 (CD120a), Fas (CD95), DR3 (Wsl-1), DR4 (Trail-R1), DR5 (Trail-R2) and 
CAR-1 (Ferreira et al., 2002). Down-regulation of these receptors and mutations 
within the receptor genes render tumor cells resistant to apoptosis induced by Fas and 
other death receptors. Resistance to death receptor-mediated apoptosis allows tumor 
cells to escape from being killed by T cells and natural killer cells (Meier et al., 2000; 
Ferreira et al., 2002). In some types of tumor cells, chemotherapeutic drugs have been 
shown to induce apoptosis by up-regulating the expression of Fas-L, Fas, or other 
TNF family ligands and receptors, thus delivering apoptotic signals via an autocrine 
mechanism (Rozenfeld-Granot et al., 2001). Therefore, resistance to death 
receptor-mediated signaling can render such tumor cells resistant to chemotherapy.  
Although tumourigenesis is a multistep and complex process, in which many 
different pathways are involved, deregulated apoptosis pathway plays important roles 
in this process. Investigation of the function of apoptosis in tumourigenesis provides 
potential therapeutical methods for curing cancers.  
1.4 The introduction of DNA damage pathways 
 The most vulnerable but un-replaceable material in the cell is DNA. However, 
DNA damage induced by environmental factors or normal metabolic processes occurs 
at a very high rate. DNA damage can result from the action of endogenous reactive 
oxygen species or from stalled replication focks. In most cases, DNA damage arises 
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from exogenous sources. DNA is the main target of environmental genotoxins, 
including alkylating compounds, polycyclic aromatic hydrocarbons, biphenyls, 
heterocyclic amines, ultraviolet radiation and ionizing radiation (Roos and Kaina, 
2006). 
 The integrity of genomic DNA is constantly under threats, even in perfectly 
healthy cells. The maintenance of genomic integrity depends on the appropriate 
response to DNA damage. When DNA damage occurs, a series of cellular responses 
are launched to protect cells against the damage. After the detection of the existence 
of DNA damage by sensor molecules, the DNA damage signals will be amplified and 
diversified by signal transducers, to a set of downstream effectors. The effectors 
trigger cellular events such as DNA repair, cell cycle checkpoints, telomere stability 
maintenance, and transcription control. When the damage is beyond proper repair, 
apoptosis occurs to minimize the genotoxicity (Harper and Elledge, 2007).  
1.4.1 Sensing the DNA damage 
 In order to maintain the genomic integrity, all types of DNA structural alterations 
must be detected, including nicks, gaps, double-strand breaks (DSBs), and numerous 
alterations that block DNA replication and transcription (Harper and Elledge, 2007). 
ATM and ATR kinases have been considered the primary activators of the cellular 
response to DNA damage (Shiloh, 2001). ATM acts as a key modulator of 
DSBs-induced cellular resposnes. When DSBs occur, the Mre11-Rad50-Nbs1 (MRN) 
mediator complex senses DSBs for ATM and recruits it to the broken DNA (Lee and 
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Paull, 2005). The inactive ATM homodimers, when recruited to the DSBs, dissociate 
and autophosphorylate on multiple residues, which are important for maintaining its 
kinase activity (Bakkenist and Kastan, 2003). The MRN complex also serves as a 
substrate of ATM and might recruit other substrates to ATM. In addition, the histone 
acetyltransferase Tip60 and the PP5 phosphatase have been recently implicated in 
ATM activation (Harper and Elledge, 2007).  
 ATR is the initiator of the DNA damage response to a wide variety of agents that 
cause replication forks to stall (Durocher and Jackson, 2001; Shiloh, 2001). When 
DNA polymerases stall, the MCM (minichromosome maintance protein) replicative 
helicases keep on unwinding DNA ahead of the replication fork, leading to the 
generation of ssDNA (Byun et al., 2005). The ssDNA is then bound by the 
single-strand binding protein complex RPA (replication protein A) (Zou and Elledge, 
2003). The ssDNA-RPA complex recruits the ATR protein through its regulatory 
subunit ATRIP, and it also recruits and activates the Rad17 clamp loader which then 
loads the PCNA-related 911 complex (Rad9-Rad1-Hus1) onto DNA (Yang and Zou, 
2006). ATR phosphorylates Rad17, 911 complex, and the newly identified TopBP1, 
leading to activation of downstream signaling. ATR kinase activity is mutually 
stimulated by these components, though precisely how each of these components 
contributes to ATR activation remains obscure. Only in budding yeast did the studies 
show that 911 complex activates the ATR on the damaged DNA (Majka et al., 2006). 
 After the cells have sensed DNA damage, the messages are passed through ATM 
and ATR to mediators, which act directly as downstream substrates of the ATM and 
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ATR kinases (McGowan and Russell, 2004). The mediators act both as recruiters of 
additional substrates and as scaffolds for complexes assembly. At the DNA damage 
site, H2AX is phosphorylated on Ser139 residue by ATM, ATR, and DNA-PK 
(Rogakou et al., 1998). The phosphorylation of H2AX leads to recruitment of Mdc1 
(Stucki and Jackson, 2006). H2AX cooperates with Mdc1 to recruit additional factors 
to the damage sites. For instance, phosphorylated Mdc1 recruits an E3 ubiquitin ligase, 
Ubc13-Rnf8, which ubiquitinates H2AX and possibly other proteins to recruit 
additional mediators (Harper and Elledge, 2007).  
1.4.2 Cell cycle checkpoints 
 In order to survive spontaneous and induced DNA damage, cells have evolved 
surveillance mechanisms. To ensure faithful replication and transmission of the 
genome, DNA damage checkpoints rapidly induce cell cycle arrest, activate DNA 
repair, maintain the cell cycle arrest until repair is completed, and then activate 
re-entry of cell cycle progression. The genetic control of cell cycle transitions upon 
DNA damage was first observed in the SOS DNA damage response pathway of 
Escherichia coli and in mammalian ataxia telangiectasia (AT) cells, which are 
defective for the ATM gene. Similar phenomena was later observed in yeast (Zhou 
and Elledge, 2000). 
 The ATM and ATR control cell cycle checkpoints mainly via their downstream 
checkpoint kinases Chk1 and Chk2 in response to DNA damage (Shiloh, 2001). Chk1 
and Chk2 kinases are two Serine/Threonine kinases that are structurally unrelated but 
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share some overlapping in substrate specificity. In response to IR, ATM is 
phosphorylated and activated, leading to Chk2 phosphorylation and activation (Kurz 
and Lees-Miller, 2004). Chk2 then phosphorylates p53 at Ser20 residue and interferes 
its binding with Mdm2. Furthermore, ATM phosphorylates Mdm2 at Ser395 residue 
and facilitates its degradation (Kurz and Lees-Miller, 2004). Taken together, 
ATM-Chk2 signaling stabilizes p53 and enhances the transcription of the downstream 
target p21, which binds to Cyclin D/Cdk4 complex and Cyclin E/Cdk2 complex and 
inhibits the cell cycle transition from G1 to S phase (Bartek and Lukas, 2001). 
Different from Chk2, Chk1 is phosphorylated at Ser345 in response to UV 
radiation and hydroxyurea treatment, but is only moderately phosphorylated in 
response to IR. Moreover, the phosphorylation of Chk1 on its Ser345 residue is 
dependent on ATR in response to UV (Liu et al., 2000). The Cdc25 phosphatases are 
essential in promoting cell cycle progression by abolishing the inhibitory 
phosphorylation of Cdks. Mammalian cells have three Cdc25 isoforms, all of which 
can be phosphorylated by Chk1 (Sanchez et al., 1997). It is reported that Chk1 
primarily phosphorylates Ser75 of Cdc25A upon UV radiation, while Chk2 
phosphorylates Ser123 upon IR, leading to Cdc25A degradation through the 
ubiquitin-mediated proteasome pathway (Hassepass et al., 2003; Chen and Sanchez, 
2004). Consequently, the inhibitory phosphorylation of Cdk2 cannot be removed, 
leading to G1/S arrest. On the other hand, Cdc25C is phopshorylated at Ser216 by 
Chk1 and Chk2. This phosphorylation creates a binding site for 14-3-3 proteins that 
sequestrate Cdc25C in cytoplasm (Peng et al., 1997). As a result, Cdc25C cannot get 
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access to Cdk1 carrying inhibitory phosphorylation on Thr14 and Tyr15, leading to 
G2/M arrest.  
In addition to the above mentioned classic pathways leading to cell cycle 
checkpoints, some other newly identified molecules are found to be involved in cell 
cycle checkpoints. When S-phase cells are exposed to IR, ATM phosphorylates and 
activates not only Chk2, but also BRCA1, and Nbs1, a component of the 
Mre11-Nbs1-Rad50 complex (Bartek and Lukas, 2001; Shiloh, 2001). The activation 
of these downstream targets is required for the proper execution of the intra-S-phase 
checkpoint. In addition, Mdc1, FANCD2 and SMC1 are also involved in S-phase 
checkpoint (Kobayashi et al., 2004). 
1.4.3 DNA repair 
 When cells are exposed to DNA damage, cell cycle progression must be 
temporarily arrested until DNA damage is repaired. The DNA repair pathways are 
mainly classified into 6 types, which are activated by specific types of DNA lesion 
(Hakem, 2008). (1) Direct reversal of DNA damage: This kind of repair does not 
require the excision of the damaged bases. For example, the mammalian 
O6-methylguanine-DNA methyltransferase (MGMT) directly removes the O6 alkyl 
adducts by transferring the alkyl group from the oxygen in the DNA to a cysteine 
residue in its active site, leading to the reversal of the base damage (Sedgwick et al., 
2007). (2) The mismatch repair (MMR) pathway: The MMR pathway plays important 
roles in repairing mismatches, which are small insertions and deletions that take place 
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during DNA replication. In human, mutations in MMR genes have been found in 
hereditary non-polyposis colorectal cancer families (Jiricny, 2006). (3) The nucleotide 
excision repair (NER) pathway: The NER is a multistep process that serves to repair a 
variety of DNA damage, including DNA lesion caused by UV, mutagenic chemicals, 
or chemotherapeutic drugs that form bulky DNA adducts (Leibeling et al., 2006). Two 
NER sub-pathways have been identified. The global genome NER (GG-NER) detects 
and removes lesions throughout the genome. The transcription-coupled NER 
(TC-NER) repairs actively transcribed genes. Mouse model studies show that NER 
impairment is associated with growth defects, excessive UV sensitivity, and increased 
skin cancer (Leibeling et al., 2006). (4) The base excision repair (BER): The BER 
pathway deals with base damage, the most common insult to cellular DNA (Wilson 
and Bohr, 2007). Two sub-pathways, short-patch BER and long-patch BER, are 
implicated. The short-patch BER typically replaces a single nucleotide, whereas the 
long-patch BER results in the incorporation of 2-13 nucleotides. Different from MMR 
and NER, mutations in BER pathway do not significantly predispose mutant mice for 
tumors (Wilson and Bohr, 2007; Hakem, 2008). (5) Non-homologous end joining 
(NHEJ): NHEJ is the predominant pathway of DSBs repair in mammalian cells 
(Kanaar et al., 2008). This repair pathway is active especially in the G1 cells, but is 
error prone. DSBs are sensed by the Ku80-Ku70 heterodimer, which in turn recruits 
the DNA-PKcs (DNA-dependent protein kinase catalytic subunit), resulting in the 
assembly and activation of the DNA-PK complex and its downstream targets 
responsible for the rejoining reaction (Collis et al., 2005; Kanaar et al., 2008; Misteli 
Introduction 
32 
and Soutoglou, 2009). (6) Homologous recombination repair (HR): As another DSBs 
repairing pathway, HR is a multistep process that operates at the S or G2 phase of the 
cell cycle (Thompson and Schild, 2002; Hakem, 2008). In HR repair pathway, a DNA 
lesion is recognized by the MRN complex, which is recruited to the DSBs to generate 
ssDNA by resection. The single-stranded ends bound by RPA, Rad51 and Rad52 
invade the homologous template, create a D-loop and a Holliday junction to initiate 
DNA synthesis and ultimately restore the genetic information that was disrupted by 
the DSBs (Misteli and Soutoglou, 2009).  
1.4.4 DNA damage-induced apoptosis   
 When cells experience DNA damage that is beyond repair or tolerance, these cells 
harboring DNA damage will be removed from the population by death. Cell death that 
follows DNA damage is not merely a consequence of inactivation of the genome. It is 
rather based on complex enzymatic reactions that might lead to apoptosis, necrosis, 
autophagy and other forms of cell death (Roos and Kaina, 2006). Apoptosis is the 
main path leading to cell death upon DNA damage. 
1.4.4.1 Apoptosis in relation to a variety of DNA lesions  
 Apoptosis can be triggered by a variety of unrepaired DNA lesions, such as 
O6MeG (O6-methylguanine), which is caused by methylating agents. O6MeG is 
repaired by Methylguanine-DNA methyltransferase (MGMT) (Roos and Kaina, 
2006). When MGMT is absent, the MMR complex activates ATR protein in response 
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to O6MeG lesions (Ochs and Kaina, 2000). The faulty of MMR complex might cause 
DSBs, leading to apoptosis via either mitochondrial or death-receptor apoptotic 
pathway depending on the status of p53 (Roos et al., 2004; Roos et al., 2007). 
 Apoptosis is also provoked by replication-blocking and transcription-blocking 
DNA lesions, which are repaired by global genomic NER and transcription-coupled 
NER, respectively (Leibeling et al., 2006). For example, if O6-chloroethylguanine is 
not repaired by MGMT, the chloroethyl group forms DNA inter-strand cross-links 
that block replication. The unrepaired replication-blocking lesions will hamper DNA 
synthesis during S phase, leading to collapse of the replication fork, the formation of 
DSBs, and subsequently the DSB-mediated apoptosis (Ludlum, 1990; Glassner et al., 
1999).  
UV radiation induces a broad spectrum of DNA lesions, including bulky adducts, 
oxidative lesions, DNA single-strand breaks and intra-strand cross-links. The 
unrepaired bulky DNA lesion blocks transcription of the proteins required for survival, 
such as JNK phosphatase, and leads to apoptosis via JNK-c-Jun-regulated FasL 
transcription (Ljungman and Zhang, 1996; Chigancas et al., 2000).  
 Many cross-linking agents, wchih induce DNA interstrand linkage, are used in 
cancer therapy. Such agents are highly toxic, and can induce a broad range of DNA 
lesions. These lesions are repaired by NER and HR. Cancer cells defective of the 
repairing systems are hypersensitive to these agents. For instance, cisplatin-induced 
DNA lesions block replication and transcription, and might induce 
replication-mediated DSBs. Subsequently, apoptosis is triggered either by DSBs or by 
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activation of the JNK and p38 pathways (Jamieson and Lippard, 1999; Dunkern et al., 
2001; Brozovic et al., 2004).  
1.4.4.2 Key pathways involved in DNA damage-induced apoptosis 
 The non-repaired DSBs are the most lethal DNA lesions, and are the main 
triggers of apoptosis by evoking ATM signaling (Ismail et al., 2005). Once activated, 
ATM phosphorylates various downstream substrates including p53. In addition to 
direct phosphorylation by ATM, p53 is also phosphorylated by Chk2. It is believed 
that at low levels of DSBs only a minor fraction of p53 is activated to drive the 
transcription of p21, eventually causing cell cycle arrest. With high levels of DSBs, 
p53 accumulates above a particular threshold and activates pro-apoptotic genes such 
as BAX, PUMA and FAS receptor (Lane, 1992). Therefore, the level of 
ATM-Chk2-p53 activation is important in DNA damage-triggered apoptosis.  
 However, p53-deficient cells do not lose their ability to undergo apoptosis. 
Crucial DNA damage can activate p53-independent apoptosis via backup systems. A 
central player is E2F1, which is released from the pocket of Rb protein during cell 
cycle progression through G1 phase. In response to etoposide- or 
camptothecin-induced DNA damage, ATM and/or ATR activate Chk2 and Chk1, 
which activate E2F1. As a result, transcription of the p73 gene is stimulated by E2F1, 
giving rise to an increased level of p73 protein (Urist et al., 2004). p73 induces 
apoptosis by transcriptional up-regulation of PUMA, NOXA, and BAX (Flores et al., 
2002). Another factor implicated in p53-independent apoptosis is NF-κB, which 
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induces the transcription of FasL gene upon reactive oxygen (Bauer et al., 1998).  
 The stress-activated protein kinases JNK and p38 are activated by a variety of 
DNA damage agents, such as UV and cisplatin. In the presence of cisplatin, JNK and 
p38 trigger apoptosis via a sustained high level of AP-1, which transcriptionally 
activates FasL (Brozovic et al., 2004). Different from cisplatin, UV stimulates a 
transient activation of JNK and p38. However, UV damage blocks transcription of 
proteins essential for survival, such as JNK phosphatase (Roos and Kaina, 2006). 
Therefore, sustained JNK activity causes apoptosis via c-Jun-regulated FasL 
transcription (Kasibhatla et al., 1998).  
1.4.5 Protein phosphatases involved in DNA damage pathway 
 The Cdc25 protein phosphatases are well-studied in the DNA damage pathway. 
In mammalian cells, Cdc25 activates both Cdk1 and Cdk2 by dephosphorylating 
Thr14 and Tyr15 residues (Russell and Nurse, 1986; Millar and Russell, 1992). 
Cdc25A dephosphorylates and activates Cyclin E/Cdk2, Cyclin A/Cdk2 and Cyclin 
B/Cdk1, whereas Cdc25B and Cdc25C primarily target Cyclin B/Cdk1 (Donzelli and 
Draetta, 2003; Busino et al., 2004). Thus, Cdc25A controls G1/S progression and 
entry into mitosis, whereas Cdc25B and Cdc25C primarily control entry into mitosis. 
The Cdc25 phosphatases are important targets of Chk1 and Chk2, which inactivate 
Cdc25 to halt cell cycle progression when DNA is damaged or incompletely 
replicated (Donzelli and Draetta, 2003; Busino et al., 2004). In the DNA damage 
pathway, Cdc25 phosphatases are under tight regulation to ensure proper cell cycle 
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arrest and DNA damage repair (Karlsson-Rosenthal and Millar, 2006). 
 In studying the DNA damage response, most attention has been attracted to the 
activation and execution of the response. Less attention has been given to the reversal 
of the response. Once the DNA repair has been successfully completed, how does the 
cell turn the signals off so that it can re-enter the normal cell cycle progression. Chk1 
is phosphorylated at Ser317 and Ser345 by ATR (Liu et al., 2000; Zhao and 
Piwnica-Worms, 2001). In 2004, it was identified that the type 1 protein phosphatase 
(PP1) Dis2 dephophorylates Chk1 at Ser345, suggesting a role of Dis2 in G2 
checkpoint recovery (den Elzen and O'Connell, 2004). Chk1 mediates the 
phosphorylation of Cdc25 on Ser287, targeting Cdc25 to ubiquitin-mediated 
proteolysis. PP1 has been shown to dephosphorylate Xenopus Cdc25 on Ser287. PP1 
may be important in allowing Cdc25 to accumulate to levels required for Cdk 
activation (Margolis et al., 2003). PP1 is also implicated in dephosphorylating p53 on 
Ser15 and Ser37 residues, thereby inhibiting the transcription activity of p53 (Li et al., 
2006). 
 It was reported that PP5 dephosphorylates DNA-PK and ATM. Although the 
results of different groups cannot be reconciled, these studies suggested a possible 
involvement of PP5 in the DNA-damage response (Wechsler et al., 2004). 
 In budding yeast, the type 2A phosphatase Pph3 mediates Rad53 (mammalian 
Chk2) and γH2A dephosphorylation. By dephosphorylating Rad53, Pph3 facilitates 
the progression through S-phase. By dephosphorylating γH2A, Pph3 participates in 
recovery from G2/M arrest (Keogh et al., 2006; O'Neill et al., 2007). The budding 
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yeast type 2C phosphatases, Ptc2 and Ptc3 are also involved in dephosphorylating 
Rad53 after HO-induced DSBs (Leroy et al., 2003).  
 In recent years, the human PP2C phosphatase Wip1 has been extensively studied. 
The function of Wip1 in regulating the homeostasis of DNA damage response has 
attracted great attention. As a phosphatase, Wip1 dephosphorylates a spectrum of 
proteins, which play essential roles in DNA damage responses, including ATM, Chk1, 
Chk2, p53, Mdm2, p38, and NF-κB. Therefore, phosphatases gradually emerge as a 
switch to turn off the DNA damage response when everything is settled down. 
1.5 Objectives 
1.5.1 To investigate the molecular mechanism of Wip1 in regulation of apoptosis 
 In the last few years, several groups have suggested that Wip1 is a negative 
regulator of apoptosis in response to DNA damage. Bulavin et al. have shown that 
tumors derived from Ppm1d-/- MMTV-Erbb2 mice possess a reduced mitotic index 
and increased levels of apoptosis compared with tumors derived from wild-type mice 
(Bulavin et al., 2004). In addition, Takekawa et al. have reported that Wip1 suppresses 
UV-induced apoptosis by negatively regulating p38/p53 signaling (Takekawa et al., 
2000). Ectopic expression of Wip1 results in the inhibition of Chk2-mediated 
apoptosis following ionizing radiation (Fujimoto et al., 2006). On the contrary, 
depletion of Wip1 by siRNA prolongs the E2F1-induced activation of p38 signaling 
pathway, resulting in an enhancement of E2F1-induced apoptosis (Hershko et al., 
2006). Recently, it was found that loss of Wip1 suppresses APCMin-driven polyposis 
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by lowering the threshold for p53-dependent apoptosis of stem cells, thus preventing 
their conversion into tumor-initiating stem cells (Demidov et al., 2007a). Taken 
together, these results suggest that Wip1 acts as an important regulator of apoptosis. 
However, it is still obscure if the regulation of apoptosis by Wip1 is induced by 
stresses other than DNA damage stress, and through which pathways does Wip1 
regulate apoptosis. Therefore, one objective of my research project is to unravel the 
role of Wip1 in regulating apoptosis. 
1.5.2 To study the regulation of Wip1 in UV-induced DNA damage response 
 Recent studies have discovered essential roles of phosphatases in terminating the 
DNA damage signaling. As an important regulator of the DNA damage pathway, 
Wip1 regulates the phosphorylation and activity of many proteins involved in the 
DNA damage signaling. It has been widely accepted that Wip1 is a homeostatic 
regulator of DNA damage-induced cellular responses. So far, very few studies have 
been done to investigate how Wip1 itself is regulated. From the very beginning, Wip1 
was identified as a wild-type p53-induced phosphatase in response to IR. However, 
later studies also found that Wip1 can be induced in a p53-independent manner. A 
conserved p53 response element has been identified in the 5’-UTR of the Ppm1d gene. 
The transcriptional regulation of Ppm1d in response to DNA damage signaling is 
mainly dependent on wild-type p53. Furthermore, Ppm1d gene also contains a 
potential cyclic AMP response element (CRE). In the absence of environmental 
stresses, the binding of CREB transcription factors may contribute to the basal 
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transcription of Ppm1d (Rossi et al., 2008). It is still obscure if Wip1 is regulated by 
other transcription factors, and if Wip1 experiences any post-translational regulation. 
Therefore, another objective of my research project is to investigate how Wip1 is 
regulated in UV radiation-induced DNA damage signaling. 
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Chapter 2 Materials and Methods 
2.1 Cell culture and transfection 
2.1.1 Cell lines 
 Human embryonic kidney epithelial cells (HEK293T), human breast 
adenocarcinoma cells (MCF-7), human osteosarcoma cells (U2OS and Saos-2), 
human colon carcinoma cells (HCT116 p53 WT and HCT116 p53 KO), and mouse 
embryonic fibroblasts (wild-type and Wip1-/- MEFs) were used in the current studies. 
Based on previous studies, Wip1 protein was up-regulated in the above-mentioned 
human cancer cell lines. Primary MEFs derived from wild-type and Wip1-/- mice were 
kindly provided by Dr D.V. Bulavin in IMCB (Choi et al., 2002), and were 
immortalized with SV40. All the other cell lines were originally obtained from the 
American Type Culture Collection (ATCC). 
2.1.2 Cell culture 
 These cell lines were routinely maintained in Dulbecco’s modified Eagle’s 
medium (DMEM) (Hyclone), supplemented with 10% (v/v) fetal bovine serum 
(Hyclone). All cells were cultured at 37ºC in a 5% CO2 humidified atmosphere.  
2.1.3 Transfection 
 HEK293T cells at 50%-60% confluence in 35mm plates (6-well plates) were 
transfected with 1-2 μg of the indicated plasmids using 4-6 μl lipofectamine 
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transfection reagent (Invitrogen). HCT116 p53 WT and HCT116 p53 KO cells at 
30%-40% confluence in 35mm plates (6-well plates) were transfected with 1-2 μg of 
the indicated plasmids using 4-6 μl lipofectamine 2000 transfection reagent 
(Invitrogen). MCF-7 cells at 50%-60% confluence in 35mm plates (6-well plates) 
were transfected with 1-2 μg of the indicated plasmids using 4 μl TransIT-LT1 
transfection reagent (Mirus Bio). The condition used for transfection was performed 
as recommended by the manufacturer’s instructions.  
2.1.4 Cell count 
 The cells were trypsinized and suspended in culture medium. 10 μl of cells were 
stained with 10 μl of 0.1% trypan blue (1:1) for 5 min. The live cells were counted 
with a hemocytometer.  
2.2 Drug treatment and UV treatment  
 The cells were seeded and cultured for 36 hr prior to treatments. Anisomycin, a 
protein synthesis inhibitor, and etoposide, an inhibitor of DNA topoisomerase II, were 
obtained from Sigma. H2O2, which induces oxidative stress, was obtained from 
AppliChem. Staurosporine, which stimulates apoptosis via activating Caspase3, was 
purchased from Alexis Biochemicals. Cycloheximide, a protein synthesis inhibitor, 
and MG132, which inhibits proteasome-mediated protein degradation, were obtained 
from Sigma. For UV treatments, culture medium was removed and the cells were 
challenged with indicated doses of UV radiation. UV irradiation was performed using 
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an XL-1500 UV Crosslinker. After UV radiation, cells were recovered in the culture 
medium for indicated hours. 
2.3 MAPK inhibitors and cell proliferation assay 
2.3.1 MAPK inhibitors 
 The p38 inhibitor SB203580 and JNK inhibitor SP600125 were purchased from 
Sigma. Equal numbers of wild-type and Wip1-/- MEFs were seeded and cultured for 
36 hr before treatment with anisomycin, etoposide, H2O2, UV and staurosporine, 
respectively. 5μM SB203580 and/or SP600125 were added to the MEFs and 
incubated for 30 min prior to the above mentioned stress treatments. 
2.3.2 MTT assay 
 After treatment with different types of stresses for 12 hr, MTS 
(3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H- 
tetrazolium, inner salt) (Promega) was applied to MEFs according to the 
manufacturer’s instructions. Absorption at 495nm was recorded at the 4 hr time point. 
Data were expressed as the means + S.D. from three independent experiments. 
2.4 Flow cytometry 
2.4.1 Live/dead assay 
 The live/dead assay was used to simultaneously investigate both the live and 
death ratios of cells by measuring two parameters of cell viability, namely 
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intracellular esterase activity and plasma membrane integrity. Higher esterase activity 
(labeled with green fluorescence) indicated live cells, represented by the dots located 
in region 4 (R4) (Fig. 2.1B). Higher membrane permeability (labeled with Texas-Red) 
indicated dead cells, represented by the dots located in region 1 (R1) (Fig. 2.1C). The 
dots located in region 3 indicated unstained cells (Fig. 2.1A), and the dots located in 
region 2 indicated double-stained cells. For the live/dead assay, equal numbers of 
wide-type and Wip1-/- MEFs were seeded and cultured for 36 hr before treatment. At 
18 hr after treatment, both the floating and attached cells were harvested and 
subjected to labeling with a live/dead assay kit (Molecular Probes) according to the 
manufacturer’s instructions. After labeling, analyses was performed using Dako 
Cytomation and the results were analyzed with Summit 4.3. In each experiment, 
30,000 events were recorded. The results shown were representatives of three 
independent experiments. 
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2.4.2 Propidium iodide labeling 
 Both wide-type and Wip1-/- MEFs were seeded and cultured for 36 hr before 
treatment. After 12 hr treatment, both the floating and attached cells were harvested, 
washed twice with PBS, and fixed in 70% ethanol. MCF-7 cells were challenged with 
indicated doses of UV radiation, and recovered for indicated hours. Both the floating 
and attached cells were harvested, washed twice with PBS, and fixed in 70% ethanol.  
DNA was stained with 50 μg/ml PI (Sigma) in PBS in the presence of 100 μg/ml 
RNaseA (Qiagen). Analyses were then performed using Dako Cytomation and the 
results were analyzed with Summit 4.3. In each experiment, 10,000 events were 
recorded. The results shown were representatives of three independent experiments. 
A B C 
Figure 2.1 Parameters for live/dead assay. (A) Wild-type MEFs were harvested 
and subjected to FACS analysis without labeling. The FACS profile provided 
parameters for cells without staining. (B) Wild-type MEFs were labeled with Calcein 
AM and subjected to FACS analysis. The FACS profile provided parameters for live 
cells with FITC labeling. (C) Wild-type MEFs were fixed with 70% ethanol. Fixed 
cells were stained with EthD-1 and subjected to FACS analysis. The FACS profile 
provided parameters for dead cells with Texas-red labeling. 
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2.5 Immunostaining and microscope 
 The cells grown on coverslips were fixed in 4% paraformaldehyde/PBS for 15 
minutes and then permeabilized with PBS containing 0.2% Triton X-100 for 15 
minutes at room temperature. Fixed cells were incubated with 10 μg/ml Hoechst 
33342 (Molecular probe) for 40 minutes. The cells were washed twice in PBS and 
then mounted with FluorSaveTM Reagent (Calbiochem) and analyzed under a 
fluorescence microscope (Olympus). 
2.6 Western bolt analysis 
2.6.1 Sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) 
 The Mini Protein II electrophoresis apparatus (Bio-Rad) was assembled 
according to the manufacturer’s instruction. The gels were cast with 0.75 mm spacer 
and ten-well comb (Bio-Rad). The resolving gel contained 8%-15% (w/v) acrylamide, 
0.48% (w/v) N-N’-methylbisacrylamide, 0.375 mM Tris-HCl pH 8.8, 0.1% (w/v) 
SDS, 0.0075% (w/v) AMPS and 0.05% (v/v) TEMED. The stacking gel contained 4% 
(w/v) acrylamide, 0.133% (w/v) N-N’-methylbisacrylamide, 0.125 mM Tris-HCl pH 
6.8, 0.1% (w/v) SDS, 0.0075% (w/v) AMPS and 0.08% (v/v) TEMED. Protein 
samples, together with protein markers (Bio-Rad) were mixed with 1/5 volume of 6X 
loading buffer [3% (w/v) SDS, 15% (v/v) glycerol, 7.5% (v/v) β-mercaptoethanol, 0.1 
M Tris-HCl pH 6.8, 0.005% (w/v) bromophonel blue] and boiled at 95ºC for 15 min. 
Electrophoresis was performed at 50 mA/gel for 1 hr at room temperature in 
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SDS-running buffer [25 mM Tris, 192 mM glycine and 0.75% (w/v) SDS]. 
2.6.2 Western blot procedure 
 After electrophoresis, proteins separated on the gels were transferred onto 
polyvinylidene difluoride membrane filters (PVDF) membrane (Pall Corporation) in 
transfer buffer [33.7 mM Tris, 256 mM glycine, 20% (v/v) methanol and 0.01% (w/v) 
SDS] at 100 Volt for 1.5 hr at 4ºC with a Mini Trans-blot Electrophoretic Transfer Cell 
(Bio-Rad). The blots were incubated in blocking buffer (5% BSA, 0.1% Tween 20 in 
TBS) at room temperature for 1 hr and then washed with 0.1% Tween 20 in TBS 
(TBST) for 5 times. After that, the blots were incubated with primary antibodies 
diluted in TBST at 4ºC overnight. Followed by 5 times washing with TBST, the blots 
were incubated with secondary antibody diluted in TBST. After 5 times washing with 
TBST, proteins on the blots were detected with ECL kit (Pierce).     
2.6.3 Antibodies 
 Anti-Wip1 (H-300 #D0403), anti-c-Jun (H-79 #D1604), anti-p38 (H-147 #I2203), 
anti-HA (#sc-7392), anti-Cyclin D1 (#sc-718), anti-Cyclin E (#sc-198), anti-Cyclin 
B1 (#sc-752), anti-p21 (#) antibodies were purchased from Santa Cruz. Anti-HA 
(#12CAS) antibody was purchased from Zymed. Anti-Flag (#F-1804), anti-α-tubulin 
(#T-5168) was obtained from Sigma. Anti-phospho-p38 Thr180/Tyr182 (#9211), 
anti-phospho-JNK Thr183/Tyr185 (#9251), anti-phospho-ATF2 Thr69/71 (#9225), 
anti-phospho-ATF2 Thr71 (#9221), anti-phospho-c-Jun Ser63 (#9261), 
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anti-phospho-c-Jun Ser73 (#9164), anti-phospho-MKK4 Thr261 (#9151), 
anti-phospho-MKK7 Ser271/Thr275 (#4171), anti-phospho-Creb Ser133 (#9196), 
anti-phospho-Chk1 Ser345 (#2348), anti-phospho-Chk2 Thr68 (#2661), phospho-p53 
Antibody Sampler Kit (#9919), anti-Caspase-3 (#9662), anti-cleaved Caspase-3 
(#9664) and anti-cleaved PARP (#9548) were purchased from Cell Signaling 
Technology. Anti-phospho-MKK4 Ser257 (#ab61112-100) was obtained from 
Abcam.  
 The secondary antibodies were either horseradish peroxidase-conjugated goat 
anti-rabbit or anti-mouse IgG (Santa Cruz Biotechnology). 
2.7 Immunoprecipitation 
2.7.1 Mammalian cell lysis 
 After transfection, cells were grown for additional 18-24 hr and harvested by the 
mammalian cell lysis buffer (50 mM Tris-HCl pH 7.4, 100 mM NaCl, 10% glycerol, 
1% Triton X-100, 1mM EDTA, supplemented with proteinase inhibitors and 
phosphatase inhibitors including 0.7 μg/ml pepstatin, 0.5 μg/ml leupeptin, 1 mM 
okadaic cid, and 1 mM Na3VO4). The resulting lysates were prepared by 
centrifugation at 16,000 ×g for 30 minutes at 4 ºC. 
2.7.2 Bradford assay for protein concentration measurement 
 To generate the standard curve for Bradford assay, 1 μg/μl stock BSA stock 
solution was diluted to gradient concentrations of 2, 4, 6, 8, 10, 12 μg/ml of the final 
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volume of 800 μl with diH2O. A total volumn of 200μl Bradford reagent (Bio-Rad) 
was mixed with each of concentration gradients and incubated at room temperature 
for 10 min, then applied for spectrometer to detect the absorbance at 595 nm 
wavelength (A595). The standard curve was generated with the X axis of protein 
amount in each of concentration gradients, and Y axis of A595 (R2>0.98).  
 To determine the concentration of unknown protein samples, 1, 2, and 3 μl of 
protein samples were diluted to a total volume of 800 μl with diH2O, followed by 
adding 200 μl Bradford reagent to the mixture. The mixtures were subjected to vortex, 
incubated in room temperature for 10 min, and applied for spectrometer at A595. The 
concentrations of the samples were calculated based on the standard BSA curve. 
2.7.3 Immunoprecipitation 
 For immunoprecipitation, Flag-tagged protein was over-expressed in HEK293T 
cells. The cells were harvested 24 hr after transfection with indicated treatments, and 
lysed in the mammalian cell lysis buffer. The lysates were subjected to centrifugation 
at 16,000×g for 30 min, and the resultant supernatants were incubated with Flag-M2 
affinity gel (Sigma) for 2-4 hr at 4ºC. After incubation, the Flag-M2 affinity gel was 
washed by mammalian cell lysis buffer for 3-5 times and boiled with 2×SDS loading 
dye at 95ºC for 15 min. The bound proteins were subjected to SDS-PAGE and 
detected by Western blot. 
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2.8 Plasmid construction 
2.8.1 Polymerase chain reaction (PCR) 
 The human Wip1 plasmid was kindly provided by D.V. Bulavin. The full length 
Wip1 and Wip1 fragments (schematics shown in Fig 2.2) were sub-cloned into 
mammalian expression vectors pXJ-40-Flag vector, pXJ-40-GFP vector, 
p3XFlag-CMV-10 vector (Sigma) and Escherichia coli. expression vector 
pGXE-4T-1 vector (GE Healthcare), respectively. The specific sense and antisense 
primers of full length Wip1 and Wip1 fragments were designed based on the human 
Wip1 DNA sequence. The primer sequences were listed bellow. PCR was performed 
with human Wip1 plasmid as the template. The reaction system adopted was 25 μl in 
total with 2.5 μl of 10 × PCR reaction buffer, 0.5 μl of 2 U/μl Tag polymerase 
(Finnzymes), 0.5 μl of 10 mM dNTP, 0.5 μl of 10 mM sense primer, 0.5 μl of 10 mM 
antisense primer and 1 μl of template vector. Following an initial 5 min denaturation 
at 95ºC, 30 cycles of PCR were performed using the following condition: denaturing 
at 95 ºC for 1 min, annealing at 55 ºC for 1 min and extending at 72 for 2 min ending 
with an additional 20 min extension at 72 ºC.  
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 Wip1-HindIII-sense: 5’- AGC TTA AGC TTA TGG CGG GGC TGT ACT CG-3’ 
 Wip1-BglII-sense: 5’- GAT CTA GAT CTA TGG CGG GGC TGT ACT CG-3’ 
 Wip1-BglII-antisense: 5’- GAT CTA GAT CTT CAG CAA ACA CAA ACA GTT 
TT-3’ 
 Wip1-SalI-antisense: 5’- GTC GAC GTC GAC TCA GCA AAC ACA AAC 
AGT TTT CC-3’ 
 DN-HindIII-sense: 5’- AAG CTT AAG CTT GGC GGC GAA GTC TCG G-3’ 
 FC-HindIII-sense: 5’- AAG CTT AAG CTT GCC ATA GTA ATC TGC ATC 
TC-3’   
 FN-SalI-sense: 5’- GTC GAC GTC GAC ATG GCG GGG CTG TAC TCG-3’ 
 FN-XhoI-antisense: 5’- CTC GAG CTC GAG GAT GCA GAT TAC TAT GGC 
AC-3’ 
 FN-BglII-antisense: 5’- AGA TCT AGA TCT GAT GCA GAT TAC TAT GGC 








Figure 2.2 Schematics of full length Wip1 and Wip1 fragments. 
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AC-3’ 
2.8.2 PCR products purification 
 PCR products were subjected to gel electrophoresis for analysis. The identified 
target bands were cut from the gel and subjected to QIAquick Gel Extraction Kit 
(Qiagen). The gel containing the target bands were melted at 50 ºC by adding 3 
volumes (relative to the band weight) of buffer QG (solubilization and binding buffer) 
for 15 min. The melting solution was loaded into the spin column and centrifuged at 
13,000 × g for 1 min. Subsequently, the column was washed by adding 0.75 ml of 
buffer PE (wash buffer) followed by centrifugation. The flow-through was discarded 
and the PCR products were eluted with 20-30 μl of elution buffer (EB; 10 mM 
Tris-HCl, pH 8.5) by centrifugation at 13,000 × g for 1 min. 
 PCR products can also be retrieved directly using QIAquick PCR Purification Kit 
(Qiagen). 5 volumes of buffer PB (Binding buffer) was added to the PCR sample and 
the mixture was added to the spin column. The column was centrifuged at 13,000 × g 
for 1 min and washed with 0.75 ml of buffer PE. After spinning for 1 min, PCR 
products were eluted with buffer EB from the column.  
2.8.3 Restriction digestion 
 The purified PCR products and the targeting vector were subjected to double 
restriction digestion. For the digestion of PCR products, 20 μl reaction system was 
adopted. In each reaction, 1 μl of both enzymes (1U/μl) were added with 2 μl of 10 × 
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reaction buffer and 0.2 μl of 100 × BSA. The volume of PCR products is dependent on 
the band density of the PCR product. For the digestion of targeting vectors, a total 
volumn of 20 μl reaction system was adopted. In each reaction, 2 μl of both enzymes 
(1U/μl) were added with 2 μl of 10 × reaction buffer and 0.2 μl of 100 × BSA. 2 μl of 
the targeting vector was added to the reaction system. Both the reaction systems were 
top up to 20 μl with diH2O and incubated in 37ºC water bath for 3-5 hr.  
 The digestion products were subjected to gel electrophoresis and purified using 
the QIAquick Gel Extraction Kit (Qiagen). 
2.8.4 DNA ligation and transformation 
 The digested PCR products were ligated into the target vector. The whole reaction 
volume was 10 μl, containing 1 μl of T4 ligase (1 U/ μl, Promega), 1 μl of 10 × ligase 
buffer, 1 μl digested vector, 7 μl digested PCR product. The ligation mixture was 
incubated at 16ºC overnight. 
 For the transformation, the ligation products were added into 100 μl of E. coli 
DH5α competent cells and incubated on ice for 30 min. The mixture was heated at 
42ºC for 90 seconds and cooled immediately on ice for 5 min. Subsequently, 1 ml of 
LB medium was added to the reaction tube and incubated at 37ºC for 1 hr. After 
incubation, the solution was spinned down. The supernatant was discarded except 
around 50 μl were kept in the tube. The pellet was resuspended in the remaining 
solution and was spread onto the LB plate supplemented with appropriate antibiotics. 
The plates were incubated at 37ºC overnight. The grown colonies were picked up for 
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culture and plasmids were extracted for further examination by restriction digestion 
and DNA sequencing.    
2.8.5 DNA sequencing 
 The sequencing reactions were carried out with the ABI PRISM® BigDyeTM 
Terminator Cycle Sequencing Ready Reaction Kit (Applied Biosytems). The 20 μl 
reaction contained 2 μl of Terminator Ready Reaction Mix (BigDye terminators), 4 μl 
of 5 × reaction buffer, 3.2 μl of 1 mM sequencing primer, 200-500 ng of template 
DNA. PCR was performed for 27 cycles and the conditions were as followed: 96ºC 
for 30 seconds, 50ºC for 10 seconds and 60ºC for 30 seconds. 
 When the sequencing PCR reaction was completed, the reaction products were 
precipitated with NaOAc/ethanol mixture (2 μl of 3 M NaOAc pH 4.6 and 50 μl of 
95% ethanol). The solution was mixed and incubated at room temperature for 15 min 
followed by centrifugation at 13,000 × g for 15 min at room temperature. The 
supernatant was discarded and the pellet was washed with 70% ethanol twice. During 
each washing, the pellet was incubated in 70% ethanol for 5 min and centrifuged for 5 
min. After washing, the pellet was air-dried and dissolved in 10 μl HiDi. The samples 
were sent for sequencing in the sequencing machine (ABI377 sequencer system).  
2.9 RNA extraction and reverse transcription (RT)-PCR 
2.9.1 RNA extraction with Trizol 
 RNA from cultured cells was extracted using the Triazol Reagent (Invitrogen) 
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according to the manufacturer’s protocol. The culture medium was removed from the 
cell mono-layer. The cells were washed twice with TBS. After washing, 1ml Trizol 
reagent was added to a 35 mm culture dish, and passing the cell mono-layer several 
times through a pipette. The homogenized sample was incubated at room temperature 
for 5 min and 0.2 ml chloroform per 1 ml Trizol was added into the sample. The tube 
was shaken vigorously for 15 second and incubated for 2-3 min at room temperature. 
The clear aqueous phase was completely separated from the red organic phase by 
centrifugation at 12,000 × g for 15 min at 4ºC. The volume of the aqueous phase is 
about 60% of the volume of Trizol reagent used for homogenization. The RNA was 
precipitated from the aqueous phase by mixing with 0.5 ml of isopropyl alcohol per 1 
ml of Trizol reagent used. After incubation at room temperature for 10 min and 
centrifuge at no more than 12,000 × g for 10 min at 4ºC, the RNA precipitated as a 
gel-like pellet. The supernatant was discarded. The RNA pellet was washed once with 
1ml of 75% ethanol per 1ml of Trizol reagent used for initial homogenization. The 
RNA sample was vortexted and centrifuged at no more than 7500 × g for 5 min at 4ºC. 
After washing, the RNA pellet was briefly air-dry and dissolved in RNase-free water 
and incubated for 10 min at 55-60ºC. 
2.9.2 cDNA synthesis 
 After isolation, 1 μg of total RNA was reverse-transcribed at 42ºC for 1 hr by the 
SuperScript II Reverse Transcriptase (Invitrogen). The 20 μl synthesis reaction was 
set up as follows: 4 μl of 5 X first strand buffer, 1 μl of dNTP mix (10 mM each), 2 μl 
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of 0.1 M DTT, 0.25 μl of reverse transcriptase (200U/ μl) and 1 μl oligo-dT18 (100 
μM).   
2.10 Semi-quantitative RT-PCR and quantitative real-time PCR 
2.10.1 Semi-quantitative RT-PCR 
 The PCR reaction was conducted in a total volumn of 20 μl reaction mixture 
consisting of 0.6-1.0 μM of target gene primers, 0.1-0.4 μM of GADPH primers, 0.2 
mM dNTP, 1.5 mM MgCl2, 1 × PCR buffer, 0.25 U Taq (iDNA), and 1 μg cDNA. The 
primer sequences for FasL, Tp53, Cyclin D1, Ppm1d, and GADPH were listed bellow. 
Thermal cycle condition used for were: 28 cycles for FasL, 24 cycles for Tp53 and 
Cyclin D1, 30 cycles for Ppm1d of 94ºC for 30 seconds, 60ºC for 30 seconds and 72ºC 
for 1 min, followed by 72ºC for 10 min. The PCR products were subjected to gel 
electrophoresis and analyzed using Gel Doc Imaging System (Bio-Rad).  
FasL-sense: 5’- CGG TGG TAT TTT TCA TGG TTC TGG-3’   
FasL-antisense: 5’- CTT GTG GTT TAG GGG CTG GTT GTT-3’ 
Tp53-sense: 5’- CCC TCT GAG CCA GGA GAC ATT TTC-3’  
Tp53-antisense: 5’- GGC AGC GTC TCA CGA CCT CC-3’  
Cyclin D1-sense: 5’- ACC CTG ACA CCA ATC TCC TC-3’  
Cyclin D1-antisense: 5’- CTT GCG GAT GGT CTG CTT GTT CTC A-3’  
Ppm1d-sense: 5’- AGT GAT GGA CTT TGG AAT AT-3’  
Ppm1d-antisense: 5’- AGG GCA GGT ATA TGG TCC TTA GA-3’  
GADPH-sense: 5’- GTG GCA AAG TGG AGA TTG TTG CCA-3’  
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GADPH-antisense: 5’- GAG ACA ACC TGG TCC TCA GTG TAG-3’  
2.10.2 Quantitative real-time PCR     
 The quantitative real-time PCR was performed using the SYBR® Green PCR 
Master Mix (Applied Biosystems). In the 5 μl reaction mixture (384-well plate), 2.5 μl 
of SYBR® Green, 0.1-0.5 μg cDNA, 0.2 μM primers were added. The 384-well plate 
was subjected to the 7900HT Fast Real-Time PCR System. Primer sequences for the 
quantitative real-time PCR were described as the following. Relative gene expression 
was standardized against GADPH. 
 Ppm1d-1-sense: 5’- GAA GAT GAG TTA TAC CTG AAC CTG AC-3’ 
 Ppm1d-1-antisense: 5’- CGAGCTATCTCAGCTGAAACCTCTA-3’ 
 Ppm1d-2-sense: 5’- TCCACACTCTTGACCCTCAGAAGCA-3’ 
 Ppm1d-2-antisense: 5’- CTGCTCGGAGCATACGCTGCCTC-3’ 
 Tp53-sense: 5’- CAC TAA GCG AGC ACT G-3’ 
 Tp53-antisense: 5’- GGA GGT AGA CTG ACC C-3’ 
 p21-sense: 5’- ATT AGC AGC GGA ACA AGG AGT CAG ACA T-3’ 
 p21-antisense: 5’- CTG TGA AAG ACA CAG AAC AGT ACA GGG T-3’ 
 GADPH-sense: 5’- AGC AAT GCC TCC TGC ACC ACC AAC-3’ 
 GADPH-antisense: 5’- CCG GAG GGG CCA TCC ACA GTC T-3’ 
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2.11 Expression and purification of recombinant proteins in Escherishia. coli 
2.11.1 Protein expression in Escherishia. coli 
 To produce the recombinant GST-Wip1 and GST-Wip1 FN proteins, E. coli BL21 
stain was transformed with pGEX-4T-1 Wip1 or pGEX-4T-1 FN constructs, 
respectively. Briefly, a single clone was picked, inoculated into 10 ml terrific broth 
(TB), and cultured at 37ºC, 250 rpm overnight. To express the recombinant protein, 
the 10 ml culture was transferred into 1 L terrific broth. After OD600 of the culture 
reached 0.8, a final concentration of 0.4 mM IPTG (Isopropyl 
β-D-1-Thiogalactopyranoside) was introduced to induce the protein expression for 3 
hr at 37ºC, 250 rpm. After induction, the cells were harvested by centrifugation.   
2.11.2 Purification of recombinant proteins  
 The E. coli pellet was resuspended in 10 ml bacterial lysis buffer (50 mM 
Tris-HCl pH8.0, 500 mM NaCl, 1% Triton X-100, 5% glycerol, 2 mM EDTA) 
complemented with protease inhibitor cocktail tablets (Roche). After ultrasonic 
disruption, cell debris was removed by centrifugation at 20,000 × g for 30 min at 4ºC. 
One ml glutathione-agarose bead slurry (Amersham) was equilibrated twice with 5 ml 
of bacterial lysis buffer, and spinned down at 500 × g for 5 min. The bacterial lysates 
were incubated with the equilibrated glutathione-agarose beads for 3 hr at 4ºC. After 
incubation, the beads were washed with lysis buffer for 5 times and spinned down at 
500 × g for 5 min at 4ºC to remove the unspecific binding on the GST beads.   
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 The GST-Wip1 and GST-Wip1 FN beads were either subjected to 30 unit 
thrombin (Sigma) digestion in the presence of 1 mM DTT at 4ºC overnight, or 
subjected to 10 mM reduced-L-glutatione exchange at 4ºC overnight. The beads were 
separated with solution by centrifugation at 500 × g for 5 min at 4ºC. The supernatant 
was concentrated to < 500 μl with Amicon Ultra (MILLIPORE) at 3000 rpm at 4ºC. 
The resultant proteins were stored at -80ºC for further use.  
2.12 In vitro phosphatase assay 
 The in vitro phosphatase assay was performed using the Serine/Threonine 
Phosphatase Assay System (Promega). 
2.12.1 Preparation of human Flag-Wip1 protein 
 The pXJ-40-Flag Wip1 expression vector was over-expressed in HEK293T cells. 
The cells were harvested with mammalian cell lysis buffer 24 hr after transfection. 
The cell debris was separated by centrifugation at 13,000 × g for 30 min at 4ºC. The 
Flag-M2 affinity gel (Sigma) was equilibrated twice with mammalian cell lysis buffer 
and spinned down at 8,000 rpm for 1 min at 4ºC. The cell lysates were incubated with 
the equiliberated Flag-M2 affinity gel for 2 hr at 4ºC. After incubation, the Flag-M2 
affinity gel was washed with mammalian cell lysis buffer for 5 times. After washing, 
the Flag-M2 affinity gel was equilibrated once with phosphatase reaction buffer (50 
mM Tris-HCl pH7.4, 50 mM MgCl2, 0.1 mM EGTA, 1mg/ml BSA, 0.02% 
β-mercaptoethanol).  
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2.12.2 Phospho-peptides 
 Two phospho-peptides derived from MKK4 and one phospho-peptide derived 
from p38 were synthesized by Shanghai Science Peptide. The sequences of the 
phospho-peptides were shown as the follows. A non-phosphopeptide derived from 
Cdc25 was used as a negative control substrate. 
MKK4 pS257: Ac-GQLVDpS257IAKTR-amide 
MKK4 pT261: Ac-DSIAKpT261RDAG-amide 
p38 pT180: Ac-TDDEMpT180GYVAT-amide 
2.12.3 Phosphate standard curve 
 The phosphate standards were made by diluting the 1 mM phosphate standard 
(Provided by the kit) with the supplied phosphate-free water. A series of gradient 
concentrations of phosphate: 0, 2, 4, 10, 20, and 40 μM were generated. For each 
concentration gradient, 50 μl solution was mixed with 50 μl Molybdate Dye/Additive. 
The dye color was developed for 15 min, and the absorbance at 600 nm was measured 
with a plate reader. The phosphate standard curve was generated with OD600 as Y axis 
and phosphate concentration as X axis (Fig. 2.3).  
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2.12.4 Phosphatase assay 
 The in vitro phosphatase assay has been described previously (Lu et al., 2004; Lu 
et al., 2007). The reaction mixture contains 200 nM phospho-peptide, Flag-M2 
affinity gel conjugated-Wip1 derived from one 10 cm dish of the transfected 
HEK293T cells. The reaction mixture was top up to 120 μl with phosphatase reaction 
buffer. The reaction was conducted at 30ºC for 40 min. The tubes were gently shaked 
every 3 min. When the reaction was finished, the Flag-M2 affinity gel was pelleted by 
centrifugation at 8,000 rpm for 1 min at 4ºC. For each sample, 60 μl supernatant was 
mixed with 60 μl of the Molybdate Dye/Additive, and the mixture was added into one 
well of the 96-well plate. The dye color was developed for 15 min, and the absorbance 
at 600 nm was measured with a plate reader.    
Figure 2.3 Phosphate standard curve. 
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Chapter 3 Loss of Wip1 sensitizes cells to stress- and DNA damage-induced 
apoptosis 
3.1 Background of MAPK pathway 
3.1.1 Introduction of MAPK pathway 
 Cells integrate external stress signals and decide cell fates on an ongoing basis. 
Developmental programs and environmental agents trigger evolutionarily conserved 
kinases that relay signals mediating proliferation, survival, death, or cell cycle arrest. 
The mitogen-activated protein kinases (MAPKs) are the family of kinases that 
transduce signals from the cell membrane to the nucleus in response to a wide range of 
stimuli (Wada and Penninger, 2004). MAPKs are serine/threonine kinases that 
phosphorylate their specific substrates at serine and/or theonine residues upon 
stimulation (Davis, 2000; Johnson and Lapadat, 2002). The MAPK signaling 
pathways control key cellular functions, including gene expression, differentiation, 
proliferation, motility, metabolism, apoptosis, and participate in a number of diseases 
including chronic inflammation and cancer (Chang and Karin, 2001; Johnson and 
Lapadat, 2002).  
Fig. 3.1 depicts the conserved MAPK signaling pathways (Wada and Penninger, 
2004). Conventional MAPKs consist of three family members: the extracellular 
signal-regulated kinase (ERK); the c-Jun NH2-terminal kinase (JNK); and the p38 
MAPK. Each MAPK family member has its own subfamilies: ERKs (ERK1 and 
ERK2), JNKs (JNK1, JNK2, and JNK3), and p38 MAPKs (p38 MAPKα, p38 
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MAPKβ, p38 MAPKγ, and p38 MAPKδ) (Seger and Krebs, 1995; Tibbles and 
Woodgett, 1999; Widmann et al., 1999). ERK5 (ERK5); ERK3s (ERK3, p97 MAPK, 
ERK4) and ERK7s (ERK7, ERK8) are also subfamilies of MAPKs (Bogoyevitch and 
Court, 2004). However, the functions and activation pathways have not been fully 
characterized regarding these three subfamilies.  
 
ERK1/2, also known as p44MAPK and p42MAPK, respectively, are the first 
identified mammalian MAPKs. The mammalian ERK MAPK pathway is implicated 
in multiple physiological processes, including proliferation, differentiation and 
survival. The activation of ERK1/2 induces proliferative signals that contribute to 
normal and cancerous cell growth. Consistently, aberrant activation of the ERK 
pathway is frequently found in many cancer types (Bogoyevitch and Court, 2004). 
Figure 3.1 Schematics of the conserved MAPK pathways. (This Figure was 
adapted from Wada et al. 2004) 
Wip1 in Stress-induced Apoptosis 
63 
Both JNKs and p38 MAPKs are simultaneously activated in response to a variety of 
cellular and environmental stresses such as DNA damage, changes in osmolarity, heat 
shock, inflammatory cytokines, shear stress, and oxidative stress (Wada and 
Penninger, 2004).  
 MAPKs regulate a lot of cellular functions at least partially through the mediation 
of AP-1 activation. The transcription factor AP-1 is involved in cellular proliferation, 
transformation and death. AP-1 is not a single protein, but a series of dimeric basic 
region-leucine zipper proteins that belong to the Jun, Fos, Maf and ATF sub-families 
(Wagner, 2001; Shaulian and Karin, 2002). AP-1 activity is induced by growth factors, 
cytokines, neurotransmitters, hormones, cell-matrix interactions, bacterial and viral 
infections, and a variety of physical and chemical stresses (Wagner, 2001; Shaulian 
and Karin, 2002). These stimuli activate MAPK cascade, and induce AP-1 activity 
through the MAPK-mediated phosphorylation of distinct substrates.  
3.1.2 MAPK pathway and apoptosis 
 JNKs are directly phosphorylated at the conserved threonine and tyrosine 
residues by the dual-specific kinases MKK4 and MKK7, which are activated by 
upstream kinases such as ASK1, MLK-3, and MEKK1 (Wada and Penninger, 2004). 
JNK activation triggers apoptosis in response to many types of stresses, including UV 
radiation, IR, protein synthesis inhibitors (anisomycin), hyperosmolarity, heat shock, 
anticancer drugs, peroxide, and inflammatory cytokines (Westwick et al., 1995; Chen 
et al., 1996; Zanke et al., 1996). One critical role of JNK appears to be the regulation 
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of AP-1 transcription activity, especially in stress- and cytokine-mediated AP-1 
activation (Davis, 2000). Upon activation, JNK phosphorylates and activates a series 
of transcription factors, including c-Jun and ATF2 as well as non-transcription factors 
such as BCL-2 and BCL-XL, thereby mediating stress-induced apoptosis (Gupta et al., 
1995; Karin, 1995; Davis, 2000). Previous studies reported that over-expression of 
dominant-negative MKK4, inactive c-Jun or dominant-negative MEKK1 inhibits 
apoptosis. It has been deduced that ASK1/MEKK1/other upstream kinases 
sequentially activate MKK4/MKK7, JNK, and c-Jun signaling cascade and 
eventually induce apoptosis.  
 Similar to the JNK pathway, p38 MAPK is activated by dual-specific kinases 
MKK3 and MKK6, which are target by ASK1, MEKK2, and Tak1 (Seger and Krebs, 
1995; Waskiewicz and Cooper, 1995; Tibbles and Woodgett, 1999). Extensive studies 
indicated that the p38 MAPK pathway is required for apoptosis and survival 
depending on cell types and conditions. Both biochemical and genetic studies indicate 
that p38 MAPK pathway is involved in T cell apoptosis during T cell development. 
And such regulation is dependent on differential expression patterns and expression 
levels of MKK3 and MKK6 (Tanaka et al., 2002). It is also reported that p38 MAPK 
may regulate apoptosis via the activation of its downstream binding partners, such as 
MAPKAPK2 (Wang et al., 2002). Recent studies revealed that p38 MAPK regulates 
cell cycle arrest upon exposure to DNA damage stress (Bulavin et al., 2001). 
Therefore, it has been proposed that the effects of p38 MAPK pathway on the 
regulation of apoptosis may be associated to its relevance with DNA damage-induced 
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cell cycle arrest.  
3.1.3 MAPK and Wip1 
 The p38 MAPK is the first identified substrate of Wip1, which dephosphorylates 
p38 on its conserved Thr180 residue. By dephosphorylating p38, Wip1 suppresses the 
activity of p38 and inhibited DNA damage-induced apoptosis (Takekawa et al., 2000). 
It has been widely studied that PP2Cs act as negative regulators of the stress MAPK 
signaling pathway (Lammers and Lavi, 2007). Although previous study has ruled out 
the possibility that Wip1 regulates the phosphorylation and activation of JNK1, Wip1 
may regulate stress MAPK pathways by other means (Takekawa et al., 2000). Several 
pieces of previous studies have speculated the possible roles of Wip1 in apoptosis. We 
are interested in investigating the function of Wip1 in regulating apoptosis induced by 
DNA damage and other environmental stimuli, in which the MAPK pathways may be 
implicated. 
3.2 Results 
3.2.1 Effects of Wip1 on cell death by various types of stress stimuli 
To elucidate whether Wip1 is involved in cell death, we treated wild-type and 
Wip1-/- MEFs with different external stimuli such as anisomycin, etoposide, UV 
radiation, H2O2 and staurosporine. The cytotoxic responses of the MEFs were 
assessed by measuring the metabolic activities of viable cells using MTS. As shown 
in Fig. 3.2A, in response to anisomycin treatment, Wip1-/- MEFs displayed a 
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significantly lower live cell ratio compared with wild-type MEFs (29.6% of Wip1-/- 
MEFs compared to 56.1% of wild-type MEFs). Upon etoposide treatment, wild-type 
MEFs displayed a live cell ratio as high as 97.4%, whereas in Wip1-/- MEFs this ratio 
was much lower at 28.4%. Similarly, Wip1-/- MEFs showed a lower live cell ratio than 
wild-type MEFs in response to UV radiation, H2O2 and staurosporine treatments (Fig. 
3.2A). To exclude factors other than cell death as a cause of lower metabolic activity 
in Wip1-/- MEFs, we performed a live/dead assay. As shown in Fig. 3.2B, the control 
wild-type and Wip1-/- MEFs displayed similar dead cell ratio and live cell ratio. In 
response to anisomycin treatment, wild-type MEFs displayed a dead cell ratio of 
3.57% and a live cell ratio of 87.49% (Fig. 3.2B). However, Wip1-/- MEFs displayed a 
higher dead cell ratio of 37.15% and a lower live cell ratio of 34.56%. In agreement 
with the results of the cytotoxicity assay, Wip1-/- MEFs displayed a markedly higher 
dead cell ratio than wild-type MEFs upon exposure to all five tested stimuli (Fig. 
3.2B). Our results indicate that loss of Wip1 sensitizes MEFs to cell death resulting 
from different types of stress stimuli.  
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Figure 3.2 Antagonistic function of Wip1 during stress-induced cell death. 
Both wild-type and Wip1-/- MEFs were mock treated or treated with 10 μM 
anisomycin, 10 μg/ml etoposide, 15 μM H2O2, 50 J/m2 UV, and 1 μM staurosporine, 
respectively. (A) after 12 hr of treatment, MTS was applied to the cells for 
cytotoxicity assay. Live cell ratios were then determined by normalization of the 
readings for treated cells to the readings for mock treated cells. The data were 
expressed as the means + S.D. from three independent experiments. (B) after 18 hr 
of treatment, the cells were harvested live and stained with 0.1 μM calcein AM and 
1 μM EthD-1. The labeled cells were then subjected to FACS analysis immediately. 
The results were representatives of three independent experiments. 
A 
B 
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3.2.2 Loss of Wip1 sensitizes MEFs to stress-induced apoptosis 
To further elucidate the possible role of Wip1 in apoptosis, we examined the 
apoptotic responses of wild-type and Wip1-/- MEFs to anisomycin and etoposide, 
respectively. As shown in Fig. 3.3A, after 18 hr of treatment with these agents, Wip1-/- 
MEFs displayed more malformed nuclei with condensed DNA (white arrows) 
compared with wild-type MEFs. PI staining was also performed to reveal the ratio of 
apoptotic cells in wild-type and Wip1-/- MEFs upon stresses. As shown in Fig. 3.3B, 
after 12 hr of treatment with anisomycin, the ratio of sub-G1 apoptotic cells increased 
from 3.24% to 11.48% in Wip1-/- MEFs. Similarly, in response to etoposide, Wip1-/- 
MEFs displayed a substantial increase in the apoptotic cell ratio (from 3.24% to 
16.51%; Fig. 3.3B). In contrast, no significant changes were observed in wild-type 
MEFs treated with anisomycin as compared to the mock treated control. However, 
wild-type MEFs exhibited a strong G2/M checkpoint and few apoptotic cells upon 
etoposide treatment, in agreement with previous reports (Cliby et al., 2002; Rossi et 
al., 2006). 
Two apoptotic markers, cleaved caspase-3 and cleaved poly-(ADP-ribose) 
polymerase (PARP), were examined in wild-type and Wip1-/- MEFs upon stress 
treatments. As shown in Fig. 3.3C and D, after 6 hr of treatment, both anisomycin and 
etoposide evoked a more dramatic accumulation of cleaved caspase-3 and cleaved 
PARP in Wip1-/- MEFs compared with wild-type. UV radiation and H2O2 also 
stimulated a more significant increase in the protein levels of cleaved caspase-3 and 
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cleaved PARP in Wip1-/- MEFs compared with wild-type (Fig. 3.3E and F). Taken 
together, our results indicate that Wip1-deficient MEFs are more sensitive to external 
stress-induced apoptosis, suggesting that Wip1 may act as a negative regulator of 
apoptosis and regulates apoptosis induced by other stresses in addition to those 
induced by DNA damage. 






Figure 3.3 Sensitization of Wip1-/- MEFs to apoptosis induced by 
environmental stresses. Wild-type and Wip1-/- MEFs were mock treated or 
treated with 10 μM anisomycin and 10 μg/ml etoposide, respectively, (A) after 
18 hr of treatment, the cells were fixed and stained with 10 μg/ml Hoechst 
33342 to reveal nuclei.  
 
 




Figure 3.3 Sensitization of Wip1-/- MEFs to apoptosis induced by 
environmental stresses. Wild-type and Wip1-/- MEFs were mock treated or 
treated with 10 μM anisomycin and 10 μg/ml etoposide, respectively, (B) after 
12 hr of treatment, the cells were harvested, labeled with PI, and subjected to 
FACS analysis. The results were representatives of three independent 
experiments.  
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Figure 3.3 Sensitization of Wip1-/- MEFs to apoptosis induced by 
environmental stresses. Wild-type and Wip1-/- MEFs were mock treated or 
treated with 10 μM anisomycin (C), 10 μg/ml etoposide (D), 50 J/m2 UV (E), and 
15 μM H2O2 (F),  respectively. Extracts prepared at different time points after 
treatment were analyzed with anti-cleaved PARP and anti-cleaved caspase-3 
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3.2.3 Loss of Wip1 sustains the activation of p38 and JNK MAPKs 
 To investigate the role of Wip1 in regulating stress apoptotic pathways, we 
utilized anisomycin because it is a protein synthesis inhibitor and its involvement in 
the p38 and JNK MAPK pathways has been well characterized (Morton et al., 2004). 
Consistent with previous reports, anisomycin induced a higher level of the 
phospho-p38, but not the total p38 protein in Wip1-/- MEFs compared with wild-type 
(Fig. 3.4A, upper panel). Accordingly, Wip1-/- MEFs displayed higher level of 
phospho-ATF2, an important downstream target of p38, upon anisomycin treatment 
(Fig. 3.4A, upper panel). In addition, although the protein level of phospho-JNK was 
induced in both wild-type and Wip1-/- MEFs, the phosphorylation was found to be 
sustained for a longer time in Wip1-/- MEFs (Fig. 3.4A, lower panel). Although the 
total protein level of c-Jun was slightly increased in both wild-type and Wip1-/- MEFs, 
the later showed a substantially faster increase in the phosphorylation of c-Jun at 
residues Ser63 and Ser73 compared with wild-type MEFs in response to anisomycin 
treatment (Fig. 3.4A, lower panel). Interestingly, comparable results were found for 
etoposide (Fig. 3.4B), UV radiation (Fig. 3.4C) and H2O2 treatments (Fig. 3.4D). 
Hence, various stresses can stimulate more significant activation of p38 and JNK in 
Wip1-/- MEFs as compared to wild-type MEFs, suggesting that Wip1 acts as a 
negative regulator not only in the p38 pathway, but also in the JNK pathway.  




Figure 3.4 Enhanced activation of p38 and JNK MAPK pathways in Wip1-/- MEFs. 
Wild-type and Wip1-/- MEFs were mock treated or treated with 10 μM anisomycin (A), 10 
μg/ml etoposide (B), 50 J/m2 UV (C) or 15 μM H2O2 (D), respectively. Extracts were 
prepared at different time points after treatments. The proteins were separated on 
SDS-PAGE and probed with anti-p38, anti-p-p38 Thr180/Tyr182, anti-p-ATF2 Thr69/71, 
anti-p-JNK Thr183/Tyr185, anti-c-Jun, anti-p-c-Jun Ser63, and anti-p-c-Jun Ser73 
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3.2.4 Inhibition of Wip1 in cancer cells reconstitutes stress-induced apoptosis 
 A previous study has shown that tumors derived from Ppm1d-/- MMTV-Erbb2 
mice displayed an increased level of apoptosis compared with tumors derived from 
wild-type mice (Bulavin et al., 2004). To verify whether Wip1 negatively regulates 
apoptosis in cancer cells, we depleted Wip1 protein in U2OS and MCF-7 cells by two 
different siRNA oligonucleotides specific for Wip1 (Fig. 3.5A and B), and monitored 
their effects on anisomycin-induced apoptosis. Knockdown of Wip1 protein 
significantly sensitized U2OS cells to anisomycin-induced apoptosis. As shown in 
Fig. 3.5C, Hoechst staining revealed that Wip1 siRNA 1-transfected U2OS cells 
displayed normal nuclei, which were comparable with those transfected with negative 
control siRNA. However, after 5 hr of 5 μM anisomycin treatment, U2OS cells 
transfected with Wip1 siRNA 1 exhibited more apoptotic cells than those transfected 
with negative control siRNA (Fig. 3.5C, white arrows). Similar phenomena were also 
observed in MCF-7 cells. MCF-7 cells transfected with Wip1 siRNA 1 displayed 
37.1% sub-G1 apoptotic cells in response to 12 hr of 10 μM anisomycin treatment; 
whereas cells transfected with negative control siRNA only displayed 12.6% 
apoptotic cells (Fig. 3.5D). These results demonstrate that Wip1 inhibits stress 
induced-apoptosis not only in normal cells but also in cancer cells. 
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Figure 3.5 Sensitization of Wip1 siRNA expressing cancer cells to 
anisomycin-induced apoptosis. U2OS and MCF-7 cells were transfected with Wip1 
siRNA or scrambled negative control siRNA for 72 hr. (A) and (B) 72 hr after 
transfection, extracts were separated on SDS-PAGE and probed with anti-Wip1 
antibody. α-Tubulin was used as a protein loading control. (C) U2OS cells were 
subjected to 5 μM anisomycin treatment. After 5 hr treatment, the cells were fixed 
and stained with 10 μg/ml Hoechst 33342 to reveal nuclei.  





Figure 3.5 Sensitization of Wip1 siRNA expressing cancer cells to 
anisomycin-induced apoptosis. (D) MCF-7 cells were transfected with Wip1 siRNA 
or scrambled negative control siRNA for 72 hr. The transfected MCF-7 cells were 
subjected to 10 μM anisomycin treatment. After 12 hr of treatment, the cells were 
harvested, labeled with PI, and subjected to FACS analysis. The results were 
representatives of three independent experiments.   
 
D 
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3.2.5 Profound activation of JNK MAPK in Wip1 siRNA-transfected cancer 
cells 
 In agreement with the apoptotic phenotype, in Wip1 knocked-down U2OS cells, 
the protein levels of both cleaved caspase-3 and cleaved PARP showed a significant 
increase in response to anisomycin treatment (Fig. 3.6A). In MCF-7 cells, cleaved 
PARP proteins were also increased more significantly in Wip1 siRNA-transfected 
cells than that in negative control siRNA-transfected cells (Fig. 3.6B and C). More 
importantly, anisomycin induced a considerablely stronger activation of JNK-c-Jun 
signaling in Wip1 siRNA 1-transfected U2OS cells than in negative control 
siRNA-transected cells (Fig. 3.6A). Similarly, in MCF-7 cells, knockdown of Wip1 
using both siRNA oligonucleotides caused a moderately higher activation of 
JNK-c-Jun signaling upon anisomycin treatment (Fig. 3.6B and C). Based on these 
results, we speculate that Wip1 has a role in preventing cells from apoptosis via the 
inhibition of JNK-c-Jun signaling. 





Figure 3.6 Profound activation of JNK pathway in Wip1 siRNA expressing cancer 
cells. U2OS and MCF-7 cells were transfected with Wip1 siRNA or scrambled negative 
control siRNA for 72 hr. (A) U2OS cells were subjected to 5 μM anisomycin treatment, 
and extracts were prepared at different time points after treatment. The proteins were 
separated on SDS-PAGE and probed with anti-cleaved PARP, anti-cleaved caspase-3, 
anti-p-JNK Thr183/Tyr185, anti-p-c-Jun Ser63, and anti-p-c-Jun Ser73 antibodies. 
α-Tubulin was used as a protein loading control. (B) and (C) MCF-7 cells were 
subjected to 10 μM anisomycin treatment, and extracts were prepared at different time 
points after treatment. The proteins were separated on SDS-PAGE and probed with 
anti-cleaved PARP, anti-p-JNK Thr183/Tyr185, anti-p-c-Jun Ser63, and anti-p-c-Jun 
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3.2.6 Loss of Wip1 in MEFs leads to FasL-induced apoptosis 
To elucidate whether Wip1 regulates the transcription of genes that function 
downstream of c-Jun, we stimulated wild-type and Wip1-/- MEFs with anisomycin or 
etoposide, and examined the transcription of several c-Jun downstream genes, such as 
Tp53, Cyclin D1 and FasL (Eferl and Wagner, 2003). As shown in Fig. 3.7A and B, 
the mRNA levels of FasL were significantly up-regulated in Wip1-/- MEFs, but not in 
wild-type MEFs at 3 hr post-anisomycin treatment or 1 hr post-etoposide induction. 
However, the mRNA levels of Tp53 did not change in both wild-type and Wip1-/- 
MEFs upon these two treatments (Fig. 3.7A and B). Initially, we expected that the 
transcription of Cyclin D1 would be up-regulated in parallel with the activation of 
c-Jun, because Cyclin D1 is a well-established downstream gene of c-Jun (Bakiri et al., 
2000). However, there was no significant change in the mRNA levels of Cyclin D1 in 
both the wild-type and Wip1-/- MEFs in response to anisomycin or etoposide 
treatment, suggesting that other factors may counteract the transcription of Cyclin D1 
in this circumstance. Hence, our results demonstrate that loss of Wip1 specifically 
stimulates FasL transcription upon external stresses. 
 




Figure 3.7 Higher FasL responsiveness of Wip1-/- MEFs upon anisomycin and 
etoposide treatment. Wild-type and Wip1-/- MEFs were mock treated or treated 
with 10 μM anisomycin (A) and 10 μg/ml etoposide (B), respectively. RNAs were 
prepared at different time points and reverse transcribed. Expression levels of FasL, 
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3.2.7 Inhibition of p38 and JNK MAPKs rescues the apoptotic susceptibility of 
Wip1-/- MEFs  
To address whether Wip1 regulates apoptosis through p38 and JNK, we inhibited 
p38 and JNK with specific kinase inhibitors. The p38 inhibitor SB203580 inhibited 
the phosphorylation of ATF-2 induced by anisomycin and etoposide (Fig. 3.8A and B, 
upper panel). In addition, the JNK inhibitor SP600125 effectively inhibited the 
phosphorylation of c-Jun induced by anisomycin and etoposide (Fig. 3.8A and B, 
lower panel), suggesting that SB203580 and SP600125 specifically inhibited the 
kinase activity of p38 and JNK, respectively. Importantly, as shown in Fig. 3.8C, the 
inhibition of either p38 or JNK MAPK partially rescued the enhanced apoptosis 
phenotype in Wip1-/- MEFs upon anisomycin treatment. Simultaneous inhibition of 
both p38 and JNK MAPKs effectively rescued the susceptibility of Wip1-/- MEFs to 
anisomycin-induced apoptosis, indicating that Wip1 regulates this response 
specifically via the p38 and JNK MAPK pathways (Fig. 3.8C). To further confirm the 
results obtained from the cytotoxicity assay, we also examined the protein levels of 
both uncleaved and cleaved caspase-3 in Wip1-/- MEFs. Consistently, inhibition of 
p38 and/or JNK kinases significantly suppressed the induction of cleaved caspase-3 
protein levels in Wip1-/- MEFs upon anisomycin treatment (Fig. 3.8E). On the other 
hand, the inhibition of both the p38 and JNK MAPKs failed to rescue the higher 
susceptibility of Wip1-/- MEFs to etoposide-induced apoptosis, suggesting that 
p53-dependent, but not p38/JNK-dependent apoptotic pathway may play a major role 
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in etoposide induced-apoptosis (Fig. 3.8D). 




Figure 3.8 Inhibition of anisomycin-induced but not etopotisde-induced 
apoptosis by suppression of both the p38 and JNK. (A) and (B) Wild-type and 
Wip1-/- MEFs were subjected to treatment as indicated in the figure. Extracts 
prepared after treatment were separated on SDS-PAGE and probed with 
anti-p-ATF2 Thr69/71, anti-p-c-Jun Ser63, and anti-p-c-Jun Ser73 antibodies. 
α-Tubulin was used as a protein loading control. 
A 




   
Figure 3.8 Inhibition of anisomycin-induced but not etopotisde-induced apoptosis 
by suppression of both the p38 and JNK. (C) and (D) Equal numbers of wild-type and 
Wip1-/- MEFs were seeded and cultured for 36 hr prior to treatment. The cells were 
subjected to treatment as indicated in the figure. After 12 hr of treatment, MTS was 
applied to the cells for cytotoxicity assay. Live cell ratios were then determined by 
normalization of the readings for treated cells to the control cell measurements. The data 
were expressed as the mean + S.D. from three independent experiments. **, p<0.01; *, 
p<0.05. (E) Wip1-/- MEFs were seeded and cultured for 36 hr prior to treatment. The cells 
were subjected to treatment as indicated in the figure. Extracts prepared after treatment 
were separated on SDS-PAGE and probed with anti-cleaved caspase-3, and 
anti-pan-caspase 3 antibodies. α-Tubulin was used as a protein loading control. 
C D 
E 
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3.2.8 Wip1 regulates JNK-c-Jun signaling via mediating the activity of MKK4 
Classic MAPK signaling pathways comprise three components, which are 
sequentially activated upon extracellular signals. We therefore could not exclude the 
possibility that the upstream kinases of p38 and JNK are responsible for the activation 
of downstream apoptotic signal in the absence of Wip1. To further address the 
molecular mechanism, we examined the activation of upstream kinases such as 
MKK4 and MKK7 upon anisomycin and etoposide treatments, respectively. As 
shown in Fig. 3.9A and B, in MEFs, phospho-MKK4 increased significantly within 1 
hr after anisomycin treatment, whereas phospho-MKK7 increased at later time points. 
Compared to anisomycin, etoposide induced a moderate accumulation of 
phosphorylation in both MKK4 and MKK7 at relatively later time points (Fig. 3.9C 
and D). Markedly, both anisomycin and etoposide treatments stimulated a more 
substantial increase of phospho-MKK4 protein levels in Wip1-/- MEFs than in 
wild-type (Fig. 3.9E and F). However, the phospho-MKK7 protein levels displayed 
no significant difference between wild-type and Wip1-/- MEFs in response to stress 
treatments. Our results demonstrate that both anisomycin and etoposide selectively 
stimulate more substantial phosphorylation of MKK4 but not MKK7 in Wip1-/- MEFs 
than in wild-type MEFs, indicating that MKK4 may be preferentially regulated by 
Wip1 upon anisomycin and etoposide stimulation.  
 





Figure 3.9 Wip1 negatively regulates the phosphorylation of MKK4. Wild-type and 
Wip1-/- MEFs were treated with 10 μM anisomycin (A, B, and E) or 10 μg/ml etoposide 
(C, D, and F), respectively. Extracts prepared at different time points were separated on 
SDS-PAGE and probed with anti-p-MKK4 Thr261, and anti-p-MKK7 Ser271/Thr275 
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3.2.9 Wip1 preferentially dephosphorylates the Thr261 residue of MKK4 
 It was reported that the activation of MKK4 kinase is dependent on the 
phosphorylation at Ser257 and Thr261 residues (Herskowitz, 1995; Kyriakis and 
Avruch, 2001). To further investigate how Wip1 regulates the phosphorylation of 
MKK4, we performed an in vitro phosphatase assay using phospho-peptides derived 
from MKK4. Our results showed that Wip1 preferentially dephosphorylated the 
peptide containing phospho-Thr261 residue of MKK4, but had little effect on the 
peptide containing phospho-Ser257 residue (Fig. 3.10A). Addition of okadaic acid 
slightly inhibited the dephosphorylation effect of Wip1 on phospho-Thr261 residue in 
MKK4. However, removal of Mg2+ significantly weakened the effect of Wip1 
phosphatase on phospho-Thr261 residue. A phospho-peptide containing 
phospho-Thr180 residue of p38 was used as a positive control. Although Wip1 
displayed different dephosphorylation efficiency toward different substrate, Wip1 
really showed dephosphorylation effect on the phospho-peptide containing 
phospho-Thr261 residue of MKK4. To verify this result, we further examined the 
phosphorylation of MKK4 at Ser257 residue in MEFs upon anisomycin treatment, 
using an antibody that specifically recognizes MKK4 phosphorylated on Ser257 
residue. As shown in Fig. 3.10B, there was no distinguishable induction of 
phosphorylation at Ser257 residue of MKK4 in response to anisomycin treatment 
between wild-type and Wip1-/- MEFs. Taken together, these results indicate that Wip1 
may preferentially target the phospho-Thr261 residue of MKK4 for 
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dephosphorylation in vivo. More importantly, Wip1 may exert dual roles in regulating 
stress-induced and DNA damage-induced apoptosis through 
MKK4-p38/JNK-dependent pathway and p38/p53-dependent pathway, respectively. 







Figure 3.10 Wip1 dephosphorylates MKK4 on its phospho-Thr261 residue. (A) 
Flag-Wip1 or Flag control vector was expressed in HEK293T cells and purified by 
anti-Flag M2 affinity gel. Phosphatase assays were performed as previously described 
(Lu et al., 2004; Lu et al., 2007). In brief, A non-phosphopeptide was utilized as a 
negative control, and a known Wip1 target phospho-peptide (p38 pThr180) derived from 
p38 was utilized as a positive control (Lu et al., 2005). Free phosphate released by 
dephosphorylation was bound by molybdate and measured by O.D. absorbance at 600nm. 
The amounts of released phosphate in the assay were calculated using the phosphate 
standard curve (Fig. 2.3). The data were expressed as the mean + S.D. from three 
independent experiments. (B) Wild-type and Wip1-/- MEFs were mock-treated or treated 
with 10 μM anisomycin. Extracts were prepared at different time points after treatment. 
Proteins were separated on SDS-PAGE and probed with anti-p-MKK4 Ser257 antibody. 
α-Tubulin was used as a protein loading control. 
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3.3 Discussion 
Apoptosis is triggered by a variety of extrinsic and intrinsic signals and is tightly 
regulated by many upstream regulators. Among these regulators, p53 is of great 
importance especially in DNA damage-induced apoptosis (Manfredi, 2003; 
Motoyama and Naka, 2004; Liu and Chen, 2006). When DNA damage occurs, p53 
undergoes post-transcriptional modification and is thus stabilized. Subsequently, p53 
stimulates the transcription of a series of downstream genes, which activate cell cycle 
arrest and DNA repair (Zhou and Elledge, 2000; Shiloh, 2001; Roos and Kaina, 2006). 
When DNA damage is beyond repair, apoptosis is launched to remove potential 
genetic lesions of the organism. In addition to p53, the stress-activated p38 and JNK 
MAPKs also play essential roles in stimulating apoptosis upon a variety of 
extracellular stresses (Wada and Penninger, 2004).  
The wild-type p53-induced phosphatase 1, Wip1, acts as a homeostatic regulator 
of the DNA damage response by dephosphorylating a spectrum of proteins, including 
p38, p53, ATM, Chk1, Chk2, UNG2 and Mdm2 (Takekawa et al., 2000; Lu et al., 
2004; Lu et al., 2005; Fujimoto et al., 2006; Shreeram et al., 2006b; Lu et al., 2007). In 
the current study, we have found that the apoptotic response regulated by Wip1 is 
induced not only by DNA damage but also by ribotoxic and oxidative stresses (Fig. 
3.3). Wip1 negatively regulates stress-induced apoptosis in both normal cells (Fig. 3.3) 
and cancer cells (Fig. 3.5). In the absence of Wip1, both p38 and JNK display an 
abnormally enhanced activation upon stress exposure (Fig. 3.4). Moreover, the 
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profound activation of JNK-c-Jun signaling in Wip1-/- MEFs stimulates the 
transcription of FasL, which confers a higher sensitivity to stress-induced apoptosis.  
Anisomycin is a protein synthesis inhibitor and a specific activator for p38 and 
JNK MAPK pathways (Hazzalin et al., 1996; Hazzalin et al., 1998). It is well-studied 
that anisomycin does not stimulate p53 signaling pathway. We therefore investigated 
the roles of Wip1 in anisomycin-mediated apoptosis to dissect the p53-independent 
function of Wip1 in apoptosis regulation. In agreement with previous studies, loss of 
Wip1 leads to an enhancement of p38 activation as indicated by higher levels of p-p38 
and p-ATF2 in Wip1-/- MEFs (Fig. 3.4). It was reported that over-expression of Wip1 
does not directly reduce the phosphorylation and activation of JNK1 (Takekawa et al., 
2000). However, we have observed a sustained augmentation of JNK phosphorylation 
upon exposure to stresses in Wip1-/- MEFs (Fig. 3.4). The JNK kinases have three 
isoforms, JNK1-3. The biological function of JNKs has been intensively analyzed in 
mouse genetic models. JNK1-deficient CD4+ splenic cells and thymocyte show 
resistance to apoptosis upon stimulation of CD3 (Dong et al., 1998). JNK2-deficient 
thymocytes are resistant to anti-CD3 antibody-induced apoptosis (Sabapathy et al., 
1999). JNK1 and JNK2 double mutants die around day 11 with defective neural tube 
morphogenesis and reduced apoptosis in hindbrain regions (Kuan et al., 1999). MEFs 
derived from jnk1-/-jnk2-/- are more resistant to stress-induced apoptosis compared to 
wild-type cells (Kuan et al., 1999). Moreover, both JNK1 and JNK2 play a positive 
role in regulating the phosphorylation and transcription activity of c-Jun (Jaeschke et 
al., 2006). Compared to the ubiquitously expressed JNK1 and JNK2, JNK3 is 
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predominantly expressed in the mouse central nervous system and heart. The 
JNK3-deficient neurons in CA1 layer of the hippocampus display resistance to 
cytotoxic killing stimuli (Yang et al., 1997). A similar phenotype was observed in 
mice, which carry mutations in both Ser63 and Ser73 residues of c-Jun (Behrens et al., 
1999). Although Wip1 may not directly regulate JNK1, we could not exclude the 
possibility that Wip1 regulates JNK1 indirectly or other JNK isoforms. In addition, 
p38 and JNK kinases are activated by Gadd45α, a p53 downstream target, which is an 
important inhibitor of breast tumors (Hildesheim et al., 2002). Due to the 
up-regulation of p53 activity in the absence of Wip1, the enhanced activation of JNK 
could also result from p53-mediated transcription of Gadd45α.  
We have initially observed that various stresses lead to an abnormally elevated 
phosphorylation of c-Jun at Ser63 and Ser73 residues in Wip1-deficient MEFs (Fig. 
3.4), resulting in an activation of FasL and apoptosis (Fig. 3.7). Similar induction of 
c-Jun phosphorylation was also observed in both Wip1 siRNA-transfected U2OS and 
MCF-7 cells (Fig. 3.6), suggesting a possible involvement of Wip1 in the regulation 
of c-Jun transcription activity. c-Jun, a transcription factor of the AP-1 family, is 
implicated in many biological processes, such as proliferation, differentiation, and 
apoptosis. In response to a variety of external or internal signals, c-Jun is 
phosphorylated on its Ser63 and Ser73 residues, which lay in its transactivation 
domain (Binetruy et al., 1991; Smeal et al., 1991). Later studies found that c-Jun 
regulates neuronal apoptosis by stimulating BIM expression and the release of 
cytochrome c from mitochondria after NGF withdrawal (Whitfield et al., 2001). c-Jun 
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also regulates the transcription of another apoptosis inducer, FasL, the expression of 
which participates in DNA damage- and cytotoxic stress-induced apoptosis 
(Kasibhatla et al., 1998; Kolbus et al., 2000). JNK regulates apoptosis via many 
pathways in addition to the c-Jun-FasL signaling. Activation of JNK might stimulate 
apoptosis via phosphorylation regulation of BCL-2 family proteins and cytochrom c 
release from mitochondria (Lei et al., 2002). Because c-Jun does not possess typical 
TXY or SQ/TQ Wip1 substrate motifs, the abnormally elevated phosphorylation of 
c-Jun raises the possibility that Wip1 may regulate its phosphorylation through the 
activation of JNK family members or its upstream kinases, such as MKK4 and MKK7 
(Whitmarsh and Davis, 2007). MKK4 is an important component of MAKP signal 
cascade. It can directly phosphorylate and activate both JNK and p38 in response to 
environmental stresses (Derijard et al., 1995; Lin et al., 1995). Compared with MKK4, 
MKK7 is more specific for phosphorylation and activation of JNK (Lawler et al., 
1998). Our results show that the phosphorylation of MKK4 but not MKK7 is 
differentially regulated in wild-type and Wip1-/- MEFs upon stresses (Fig. 3.9E and F). 
The possible regulation of Wip1 on MKK4 might contribute to the simultaneous 
hyper-activation of both p38 and JNK in Wip1-/- MEFs in response to environmental 
stresses. It was reported that the phosphorylation of MKK4 is regulated by PP2Cα and 
PP2Cβ1 (Hanada et al., 1998). As a member of PP2C family, Wip1 possesses similar 
characteristics with other PP2Cs. The in vitro phosphatase assay utilizing 
phospho-peptides derived from MKK4 indicates that Wip1 preferentially 
dephosphorylates phospho-Thr261 residue but not phospho-Ser257 residue in MKK4 
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(Fig. 3.10). These results raise the possibility that Wip1 may target MKK4 for 
dephosphorylation and inactivation in vivo. Thus, Wip1 may be involved in a 
multi-step and complex mechanism in regulating MAPK pathways. 
 Tp53 and Cyclin D1 are two important downstream genes in the JNK-c-Jun 
pathway. Upon survival signals, such as growth factors, c-Jun suppresses the 
transcription of Tp53, whereas it induces the transcription of Cyclin D1 (Schreiber et 
al., 1999; Bakiri et al., 2000). In this study, we have found that, in response to 
anisomycin and etoposide treatment, the mRNA levels of Tp53 and Cyclin D1 do not 
change in cultured MEFs (Fig. 3.7). Because the AP-1 transcription factor is 
comprised of two subunits, Jun-related proteins function either as homodimers or as 
heterodimers bound to partner proteins such as Fos-related proteins, CREB or ATF-2, 
in response to different kinds of environmental stimuli (Hai and Curran, 1991; van 
Dam et al., 1993; Wagner, 2001; Shaulian and Karin, 2002; Eferl and Wagner, 2003). 
The activities of AP-1 are modulated by the differential expression of its components 
and dimer composition (Eferl and Wagner, 2003). Thus, the expression levels of AP-1 
target genes are tightly regulated by specific environmental stimuli. It would be 
interesting to study whether Wip1 regulates other AP-1 components and their 
downstream genes. 
In many cases, the p38 and JNK MAPK pathways are simultaneously activated 
by environmental stresses (Hazzalin et al., 1996; Hazzalin et al., 1998). Inhibition of 
either p38 or JNK MAPK is able to rescue the apoptosis phenotype of Wip1-/- MEFs to 
a lesser extent (Fig. 3.8C). Moreover, by inhibition of both p38 and JNK MAPKs, we 
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have successfully rescued the enhanced apoptotic response in Wip1-/- MEFs upon 
anisomycin treatment, which is known to induce apoptosis by activating both p38 and 
JNK kinases. However, inhibition of both p38 and JNK MAPKs is not able to rescue 
the enhanced apoptotic response induced by etoposide in Wip1-/- MEFs. (Fig. 3.8D), 
suggesting that etoposide induces apoptosis via a different mechanism from 
anisomycin. Unlike anisomycin, etoposide is a drug which stabilizes DNA-topo II 
complexes, thereby blocking DNA replication and causing DSBs (Baldwin and 
Osheroff, 2005). In addition to the importance of JNK in stress-induced apoptosis, 
JNK activation has also been linked to the induction of apoptosis in response to 
DNA-damaging anticancer drug etoposide (Seimiya et al., 1997). Although etoposide 
can induce apoptosis via the activation of JNK pathway, it is widely accepted that 
etoposide induces apoptosis mainly via DNA-damage pathway in a p53-dependent 
manner (Chresta et al., 1996). Taken together, we speculate that Wip1 plays diverse 
roles in preventing cells from apoptosis via multiple pathways.  
 In conclusion, our results described herein further validate the function of Wip1 
in regulating apoptosis. As a negative regulator of apoptosis, Wip1 exerts its activity 
in response to various types of environmental stresses. In addition to p38/p53 and 
ATM-Chk2-p53 signaling, Wip1 acts as a negative regulator of the MKK4-JNK-c-Jun 
singling. In response to a variety of environmental stresses, Wip1 negatively regulates 
the activation of MKK4-JNK, and the transcriptional activity of c-Jun. Subsequent 
suppression of FasL transcription inhibits stress-induced apoptosis. Moreover, siRNA 
silencing of Wip1 in cancer cells reconstitutes apoptosis induced by ribotoxic stress. 
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Together with the previous findings showing that Wip1 negatively regulates DNA 
damage-induced apoptosis, our current study provides novel evidence that Wip1 acts 
as a general “inhibitor” of apoptosis, implying that apoptosis could be reconstituted in 
cancers harboring over-expression of Wip1 phosphatase. 
Wip1 Regulation in UV 
98 
Chapter 4 The Regulation of Wip1 in UV Radiation-induced DNA Damage 
Response  
4.1 An overview of UV radiation-induced cellular responses 
4.1.1 Cellular damage caused by UV radiation 
 UV light is electromagnetic radiation emitted from the sun or artificial sources, 
invisible to the human eyes. UV radiation is divided into three areas according to its 
wavelength: UVA 315-380 nm, UVB 280-315 nm, and UVC 190-280 nm. The energy 
content of the UV radiation is inversely correlated to its wavelength, rending UVC the 
most harmful component of UV light (Tyrrell, 1994). The main cellular chromophores 
for UV radiation are DNA and reactive oxygen-generating chromophores. Due to the 
aromatic ring structures of the bases, DNA efficiently absorbs short wavelength UV 
and is the main chromophore for UVC (de Gruijl et al., 2001; Ravanat et al., 2001). 
The UV radiation induces the formation of cyclobutane-type pyrimidine dimmers 
(CPDs) and (6-4)-photoproducts (6-4PPs), which cross-link adjacent DNA bases 
(Ravanat et al., 2001). These UV-induced lesions in DNA helix cause transcriptional 
stress and stall the replication forks (Tornaletti and Hanawalt, 1999; Shiloh, 2001). 
UV-induced oxidative stress also causes additional types of DNA damage, such as 
DNA-protein cross-links and DNA-strand breaks (Kielbassa et al., 1997).  
4.1.2 Cellular defenses against UV-induced DNA damage 
 The ATM kinase is essential for IR-induced phosphorylation of checkpoint 
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proteins, while ATR is mainly involved in UV-induced phosphorylation of several 
G1/S checkpoint proteins (Mailand et al., 2000; Shiloh, 2001). The phosphorylation 
and activation of Chk1 and p53 result in up-regulation of p21, which inhibits the 
activity of Cyclin/Cdk complexes (Siliciano et al., 1997; Liu et al., 2000; Shiloh, 
2001). Moreover, Cdc25 is phosphorylated by Chk1 and targeted to the 
ubiquitin-mediated degradation, rending the Cdks inactive with the inhibitory 
threonine/tyrosine phosphorylations (Mailand et al., 2000). As a result, G1/S cell 
cycle arrest is launched so as to provide sufficient time for DNA repair. The NER 
helps mammalian cells to get rid of helix-distorting DNA adducts induced by UV 
radiation (de Laat et al., 1999). Several transcription factors take part in the UV 
response, among which p53 plays the most essential role in coordinating the cellular 
behaviors (Latonen and Laiho, 2005).  
4.1.3 Central coordinator of UV-induced DNA damage response---p53 
 The transcription factor p53 acts as an essential tumor suppressor. Over 50% of 
human tumors harbor Tp53 mutation, which renders p53 protein functionally 
impaired. In normal cells, the p53 protein level is constantly balanced between 
synthesis and degradation, by the p53 inhibitory factor Mdm2/Hdm2 (Haupt et al., 
1997; Kubbutat et al., 1997). Mdm2 ubiquitinates p53 and leads to the 
ubiquitin-proteasome degradation of p53. Furthermore, Mdm2 binds to the TAD 
domain of p53 and inhibits its transcriptional activity (Chen et al., 1993). p53 was 
firstly found to be stabilized by UV radiation in 1984 (Maltzman and Czyzyk, 1984). 
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However, the stabilization of p53 is insufficient for the p53-dependent cell cycle 
arrest and apoptosis, which at least partially require the transcriptional activity of p53. 
On the other hand, the stabilization of p53 is not required for its transcriptional 
activity. In addition, the transcriptional activity of p53 is not only dependent on the 
phosphorylation status of p53, but also dependent on the interacting partners of p53 
(Levine, 1997; Prives and Hall, 1999). Collectively, p53 is under complex regulation 
in response to UV radiation-induced DNA damage signaling. 
 p53 is able to arrest the cell cycle in G1/S boundary and G2 phase. The most 
important downstream target of p53 in regulating G1/S arrest is p21. On one hand, p21 
inhibits the activity of Cyclin E/Cdk2 complex. On the other hand, p21 binds to 
PCNA and blocks the elongation step of DNA replication (el-Deiry et al., 1993; Waga 
et al., 1994). p21 also participates in the G2 arrest by inhibiting Cyclin A/Cdk and 
Cyclin B/Cdk complexes (Li et al., 1994). However, another p53 downstream target, 
14-3-3σ, is more prominent for G2 arrest, by sequestering and inhibiting the mitotic 
Cdc25C phosphatase (Hermeking et al., 1997).  
 p53 participates in DNA repair by regulating transcription and by direct 
interaction with components of the repair machineries. p53 takes part in NER, but the 
underlying mechanism is unclear. The main transcriptional target of p53 in the NER 
complex is the repair factor p48 (Hanawalt, 2002). Another p53 target, Gadd45, is 
induced by UV radiation and may promote DNA repair by its association with PCNA 
(Smith et al., 1994). The role of p21 in DNA repair is complicated. It was reported that 
p21 may play an inhibitory role in the initial stage of NER via interacting with PCNA 
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(Waga et al., 1994). However, p21 is required to translocate PCNA from the repair 
sites in late stage of DNA repair (Stivala et al., 2001).  
 p53 induces apoptosis both in transcription-dependent and –independent manners. 
p53 transcriptionally activates several genes that are involved in both death receptor 
(Fas, DR5, and PERP) and mitochondrial (Apaf-1, NOXA, BAX, and PUMA) 
apoptotic pathways (Benchimol, 2001). From the transcription-independent 
perspective, p53 not only contributes to the shuttling of death receptors to the cell 
surface (Bennett et al., 1998), but also induces the permeabilization of the outer 
mitochondrial membrane by forming complexes with BCL-XL, BCL-2, and BAK 
(Chipuk et al., 2004; Leu et al., 2004).  
4.1.4 Live or die---how cells make the decision 
 The cells respond to UV radiation differently, depending on the cell type, the 
wavelength, and the dose of UV radiation. UVC serves as a good model to study the 
UV-induced DNA lesions. Low doses of UV radiation induce a transient cell cycle 
arrest with the transient induction of p53, whereas high doses of UV radiation induce 
apoptosis in parallel with a more sustained and more pronounced induction of p53 
(Cotton and Spandau, 1997; Reinke and Lozano, 1997; Wu and Levine, 1997; 
Latonen et al., 2001). When transient cell cycle arrest occurs, p53 significantly 
up-regulates p21 and Gadd45, representing the arrest and ongoing DNA repair 
(Reinke and Lozano, 1997). In response to high doses of UV radiation, p53 responds 
by prominently activating apoptotic targets and less induction of repair proteins or 
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Mdm2 (Latonen et al., 2001). The p53-Mdm2 pathway is differentially regulated in 
cells undergoing a transient arrest and in cells undergoing apoptosis provoked by 
different doses of UV radiation. The transiently arrested cells display a classical 
feedback loop of p53-Mdm2 regulation, while the apoptotic cells lack the 
accumulation of Mdm2 in response to p53 stabilization, leading to even higher p53 
levels (Perry et al., 1993; Latonen et al., 2001). The phosphorylation modifications of 
p53 occur dose-dependently in response to UV radiation. The phosphorylations at 
Ser46 and Ser392 of p53 have been linked to UV-induced apoptosis (Appella and 
Anderson, 2001). 
 So far, it is still not clear about how the UV-induced, p53-mediated cell cycle 
arrest is relieved. In addition, very little is known regarding when and how cells make 
the decision to launch apoptosis, and whether the failures of cell cycle arrest and DNA 
repair direct the cells to apoptosis. It was reported that Wip1 phosphatase acts as a 
homeostatic regulator of cell cycle checkpoints. The dephosphorylation of Chk1, 
Chk2, and p53 by Wip1 is indispensible in relieving the cells from arrest after the 
DNA repair is finished. How is Wip1 regulated when the cells are destined to 
apoptosis? We speculate that Wip1 should have different performances when cells are 
challenged by different doses of UV radiation.  
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4.2 Results 
4.2.1 Wip1 protein levels are differentially regulated in response to different 
doses of UV radiation 
 It has been well studied that Wip1 protein is induced in response to many 
different types of environmental stimuli, especially the DNA damage agents. UV 
radiation stimulates DNA damage and induces cell cycle arrest, DNA repair or 
apoptosis. It has been reported that Wip1 over-expression inhibits UV-induced 
apoptosis (Takekawa et al., 2000). However, it is not known how Wip1 is regulated in 
response to UV radiation. To investigate the performance of Wip1 protein upon UV 
radiation, we stimulated MCF-7 cells with different doses of UV radiation. After UV 
stimulation, the cells were recovered in the culture medium for 5 hr. In response to 
low doses of UV radiation (≤30 J/m2), Wip1 protein level was induced 5 hr after 
stimulation (Fig. 4.1). However, when cells were exposed to high doses of UV 
radiation (>30 J/m2), the protein level of Wip1 was prominently decreased 5 hr after 
stimulation (Fig. 4.1). This is the first time ever that the suppression of Wip1 protein 
level has been observed in response to DNA damage stress. We also examined the 
protein level of p53, which is a positive regulator of Wip1 protein. Compared to the 
control, p53 protein level was always induced upon different doses of UV radiation 
(Fig. 4.1). We also noticed that, at 5 hr time point, the induction of p53 was more 
significant upon lower doses of UV stimulation, but was less significant upon higher 
doses of UV stimulation (Fig.4.1). These results indicate that Wip1 protein is not 
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always up-regulated in response to DNA damage stress. Upon different doses of UV 
radiation, Wip1 protein level is differentially regulated. In addition, we speculate that 
the induction of Wip1 protein may be associated with the profound increase of p53 
upon low doses of UV radiation, while the decrease of Wip1 protein may be related to 
the weaker induction of p53 upon high doses of UV radiation. 




Figure 4.1 Wip1 protein levels in response to different doses of UV radiation. 
MCF-7 cells were seeded and cultured for 36 hr before UV treatment. The culture 
medium was removed before UV treatment. After different doses of UV 
radiation, MCF-7 cells were recovered in the culture medium for 5 hr. Proteins 
were extracted, separated on SDS-PAGE, and probed with anti-Wip1 and 
anti-p53 antibodies. α-Tubulin was used as a protein loading control.  
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4.2.2 Wip1 protein levels are differentially regulated in response to low- and 
high-dose UV radiation 
 In order to examine the detailed performance of Wip1 in response to different 
doses of UV radiation, we chose 5 J/m2 as the low-dose UV radiation, and 50 J/m2 as 
the high-dose UV radiation. MCF-7 cells were subjected to low-dose or high-dose UV 
radiation. After UV stimulation, the cells were recovered in the culture medium and 
harvested at different time points. As shown in Fig. 4.2A, in response to 5 J/m2 UV 
radiation, Wip1 protein level was induced time-dependently within 12 hr. At the 24 hr 
time point, the Wip1 protein level was decreased to the initial status (Fig. 4.2A). On 
the contrary, in response to 50 J/m2 UV radiation, Wip1 protein level was significantly 
decreased in a time-dependent manner (Fig. 4.2B). Moreover, Wip1 protein almost 
disappeared at 24 hr time point after high-dose UV stimulation, with no intention to 
return back to the initial status (Fig. 4.2B). For the first time, it has been discovered 
that Wip1 protein level is not increased upon DNA damage stress. These results 
indicate delicate regulation of Wip1 protein upon DNA damage stimulation. We 
therefore proceeded to investigate the cellular phenotypes correspondent to low- and 
high-dose of UV radiation. 




Figure 4.2 Dynamics of Wip1 protein in response to different doses of UV 
radiation. MCF-7 cells were cultured for 36 hr before UV treatment. Culture medium 
was removed before UV treatment. MEF-7 cells were subjected to 5 J/m2 (A) and 50 
J/m2 (B) UV. After UV radiation, cells were recovered in culture medium, and harvested 
at different time points as indicated in the figure. Proteins were extracted, separated on 
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4.2.3 Different cellular responses stimulated by low- and high-dose UV radiation 
 DNA damage may stimulate cell cycle arrest, DNA repair, and apoptosis, 
depending on the severity of lesions. In order to assess the cellular responses to 
different doses of UV radiation, we treated MCF-7 cells with 5 J/m2 or 50 J/m2 UV, 
and harvested cells at different time points after UV radiation. We examined the 
protein levels of cleaved PARP to determine the cellular apoptotic response. In 
response to 5 J/m2 UV radiation, the protein levels of cleaved PARP did not display 
significant changes (Fig. 4.3A). However, 50 J/m2 UV radiation induced a significant 
accumulation of cleaved PARP in a time-dependent manner, indicating apoptotic 
responses of the cells (Fig. 4.3B). Cyclin D1 protein level is an important indicator of 
the cellular proliferation rate and G1 cell cycle stage. In response to 5 J/m2 UV 
radiation, the protein level of Cyclin D1 slightly decreased in a time-dependent 
manner within 12 hr after treatment, and recovered at the 24 hr time point (Fig. 4.3A). 
When cells were subjected to 50 J/m2 UV radiation, the protein level of Cyclin D1 
profoundly decreased in a time-dependent manner within 12 hr after treatment (Fig. 
4.3B). Although the Cyclin D1 protein level slightly increased at the 24 hr time point, 
it was not comparable with the initial protein level of Cyclin D1 (Fig. 4.3B). Cyclin E 
regulates the late G1 stage and the G1/S transition. When cells were exposed to 
low-dose UV radiation, the protein level of Cyclin E increased within 5 hr after 
treatment, and gradually decreased to the normal level afterward (Fig. 4.3A). 
Differently, exposure to high-dose UV radiation drove the cellular protein level of 
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Cyclin E increase time-dependently within 24 hr after treatment (Fig. 4.3B). The 
profiles of Cyclin B1 protein level were alike between the cells exposed to either low- 
or high-dose UV radiation. The protein levels of Cyclin B1 displayed marginal 
changes within 12 hr after UV radiation, but decreased at the 24 hr time point (Fig. 
4.3A and B). The decrease of Cyclin B1 was more significant in the cells exposed to 
high-dose UV radiation (Fig. 4.3B). This might be the side-effect of the lower cellular 
viability caused by apoptosis. These results indicate that low-dose UV radiation 
stimulates transient G1/S arrest without leading cells to apoptosis. Instead, high-dose 
UV radiation stimulates sustained G1/S arrest, which may lead to apoptosis.  




Figure 4.3 Cellular responses induced by different doses of UV radiation. 
MCF-7 cells were cultured for 36 hr before UV treatment. Culture medium was 
removed before UV treatment. MEF-7 cells were subjected to 5 J/m2 (A) and 50 
J/m2 (B) UV. After UV radiation, cells were recovered in culture medium, and 
harvested at different time points as indicated in the figure. Proteins were 
extracted, separated on SDS-PAGE, and probed with anti-cleaved PARP, 
anti-Cyclin D1, anti-Cyclin E, and anti-Cyclin B1 antibodies. α-Tubulin was used 
as a protein loading control. 
A 
B 
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4.2.4 The inhibition of Wip1 protein level by high-dose UV radiation is not a 
consequence of apoptosis 
 When apoptosis occurs, the production and modification of proteins might be 
disturbed. Therefore, we could not rule out the possibility that the decrease of Wip1 
protein levels upon high-dose UV radiation is a consequence of apoptosis. To 
investigate this possibility, we treated MCF-7 cells with Z-VAD-FMK, which is an 
inhibitor of caspase proteases-mediated apoptosis. Without Z-VAD-FMK, 80 J/m2 UV 
radiation stimulated significant accumulation of cleaved PARP, and suppressed the 
protein level of Wip1 (Fig. 4.4). Z-VAD-FMK inhibited 80 J/m2 UV 
radiation-mediated accumulation of cleaved PARP (Fig. 4.4). However, we observed 
the suppression of Wip1 protein level upon 80 J/m2 UV radiation, even though 
apoptosis was blocked (Fig.4.4). This result provides important information that the 
suppression of Wip1 protein level upon high-dose UV radiation is not a conesquence 
of UV-induced apoptosis, but a direct effect of high-dose UV radiation.  




Figure 4.4 Effect of apoptosis inhibitor on high-dose UV-mediated 
inhibition of Wip1 protein level. MCF-7 cells were cultured for 36 hr before 
treatment. The cells were treated as indicated in the figure. Proteins were 
extracted, separated on SDS-PAGE, and probed with anti-cleaved PARP and 
anti-Wip1 antibodies. α-Tubulin was used as a protein loading control. 
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4.2.5 Different responses of DNA damage signaling pathways upon different 
doses of UV radiation  
 As a typical DNA lesion agent, UV radiation activates the DNA damage 
responses. Both p53 and JNK signaling pathways are important in coordinating DNA 
damage-induced cellular responses. We therefore examined the activities of these two 
signaling pathways upon low- and high-dose UV radiation. After UV radiation, both 
attached cells and detached cells were harvested and subjected to western blot 
analysis. When stimulated with 5 J/m2 UV, the protein level of p53 increased 
significantly within 5 hr after treatment, and gradually decreased to the normal level 
afterward (Fig. 4.5A). Although 50 J/m2 UV radiation triggered the accumulation of 
p53 with a slower velocity, the accumulated p53 did not decrease within 24 hr after 
treatment (Fig. 4.5B). In response to DNA damage, p53 undergoes a series of 
post-transcriptional modifications, among which the phosphorylation of N-terminal is 
an essential event. The phosphorylation of p53 on Ser15 residue helps p53 to 
dissociate with Mdm2. And the phosphorylaiton on Ser37 residue increases the 
transcriptional activity of p53 (Wahl and Carr, 2001). When MCF-7 cells were 
subjected to low-dose UV radiation, the phosphorylation on Ser15 residue of p53 
transiently increased within 5 hr after treatment, and decreased promptly afterward 
(Fig. 4.5A). However, when MCF-7 cells were challenged with high-dose UV, the 
phosphorylation on Ser15 residue of p53 not only increased but also sustained until 24 
hr after treatment (Fig. 4.5B). The phosphorylation on Ser37 residue of p53 was 
Wip1 Regulation in UV 
114 
hardly observed upon 5 J/m2 UV radiation, but was significantly up-regulated by 50 
J/m2 UV radiation (Fig. 4.5A and B). The Cyclin/Cdk inhibitor p21 is an important 
downstream target of p53. In response to DNA damage, p53-induced p21 
transcription is responsible for the G1/S arrest. Upon 5 J/m2 UV radiation, the p21 
protein level increased profoundly in a time-dependent manner within 12 hr after 
treatment, and decreased significantly at 24 hr time point after treatment (Fig. 4.5A). 
Different from low-dose UV, high-dose UV radiation induced a continuous increase 
of p21 protein (Fig. 4.5B). However, the high-dose UV-induced up-regulation of p21 
was much less prominent as compared to that induced by low-dose UV. In addition, 
the activation of JNK signaling was also differentially regulated by low- and 
high-dose UV radiation. Low-dose UV radiation hardly induced phosphorylation of 
JNK, while high-dose UV stimulated significant and long-lasting phosphorylation of 
JNK (Fig. 4.5A and B). It has been reported recently that Ppm1d is also a 
CREB-regulated gene (Rossi et al., 2008). We therefore proceeded to examine the 
phosphorylation of CREB upon different doses of UV radiation. The phosphorylation 
on Ser133 residue is essential for the activation of CREB function. When the cells 
were exposed to 5 J/m2 UV radiation, the phosphorylation of CREB on Ser133 residue 
did not show significant changes (Fig. 4.5A). However, 50 J/m2 UV radiation 
significantly stimulated the phosphorylation of CREB on Ser133 residue in a 
time-dependent manner within 12 hr after treatment (Fig. 4.5B). At 24 hr after 
treatment, the phospho-CREB protein level decreased to the normal status (Fig. 4.5B). 
These results indicate that high-dose UV stimulates higher activities of p53 and JNK 
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than does the low-dose UV. In addition, the phosphorylation of CREB is induced by 
high-dose UV treatment but not low-dose UV treatment. The diverse responses of 
DNA damage signaling pathways to different doses of UV radiation may either be the 
reasons of the different performances of Wip1 protein, or be the consequences of the 
different performances of Wip1 protein. Further experiments need to be performed to 
clarify the relationships between Wip1 and DNA damage signaling upon different 
doses of UV radiation. 




Figure 4.5 Responses of DNA damage signaling pathways upon different doses 
of UV radiation. MCF-7 cells were cultured for 36 hr before UV treatment. Culture 
medium was removed before UV treatment. MEF-7 cells were subjected to 5 J/m2 
(A) and 50 J/m2 (B) UV. After UV radiation, cells were recovered in culture medium, 
and harvested at different time points as indicated in the figure. Proteins were 
extracted, separated on SDS-PAGE, and probed with anti-p53, anti-p-p53 Ser15, 
anti-p-p53 Ser37, anti-p-JNK Thr183/Tyr185, anti-p21, and anti-p-Creb Ser133 
antibodies. α-Tubulin was used as a protein loading control. 
B 
A 
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4.2.6 The transcription of Ppm1d gene is differentially regulated in response to 
different doses of UV radiation 
 In order to understand if Wip1 is under transcriptional regulation in response to 
different doses of UV radiation, we performed real-time PCR with two sets of primers 
targeting different regions of Ppm1d gene. In response to 5 J/m2 UV radiation, the 
mRNA level of Ppm1d increased in a time-dependent manner within 12 hr after 
treatment with slight decrease at the 9 hr time point (Fig. 4.6A and B). However, 50 
J/m2 UV radiation significantly suppressed the transcription of Ppm1d within 3 hr 
after treatment (Fig. 4.6C and D). 5 hr after high-dose UV stimulation, the mRNA 
level of Ppm1d gradually increased in a time-dependent manner (Fig. 4.6C and D). 
These results suggest that transcriptional regulation of Ppm1d may be involved in 
both the induction and suppression of Wip1 protein level upon different doses of UV 
radiation.  




Figure 4.6 Transcription of Ppm1d gene in response to different doses of UV 
radiation. MCF-7 cells were cultured for 36 hr before UV treatment. Culture 
medium was removed before UV treatment. MEF-7 cells were subjected to 5 J/m2 
(A, B) and 50 J/m2 (C, D) UV. After UV radiation, cells were recovered in culture 
medium, and harvested at different time points as indicated in the figure. mRNA 
were extracted and the expression levels of Ppm1d gene were assessed using 
real-time PCR with two sets of primers targeting different regions of Ppm1d 
gene. GADPH was used as an internal control. 
A B 
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4.2.7 The effects of p53 on Ppm1d transcription upon different doses of UV 
radiation 
 Wip1 was initially identified as a wild-type p53-induced phosphatase. The 
p53-response element located in the 5’-UTR of Ppm1d gene has been identified 
recently (Rossi et al., 2008). It has been extensively studied that the induction of 
Ppm1d transcription upon DNA damage is dependent on p53. However, it is not yet 
clear if p53 is also involved in regulating the suppression of Ppm1d transcription upon 
high-dose UV radiation. In order to answer this question, we proceeded to perform the 
experiments utilizing cell lines with or without wild-type p53. U2OS and Saos2 cell 
lines are both human osteosarcoma. U2OS cells harbor wild-type p53, but Saos2 cells 
do not. Both cells were subjected to different doses of UV radiation. The transcription 
of Ppm1d was examined by real-time PCR with two sets of primers targeting different 
regions of the Ppm1d gene. In response to 5 J/m2 UV radiation, the mRNA level of 
Ppm1d increased for around 4-fold in U2OS cells at the 12 hr time point (Fig. 4.7A 
and B). However, 5 J/m2 UV radiation only triggered marginal fluctuation (<2-fold) of 
Ppm1d mRNA in Saos2 cells (Fig. 4.7E and F). When U2OS and Saos2 cells were 
both exposed to 50 J/m2 UV radiation, the transcription of Ppm1d gene was 
suppressed promptly for 80%-90% at the 3 hr time point in both cells (Fig. 4.7C, D, G, 
and H). After this transient suppression, the mRNA level of Ppm1d gene slightly 
increased in a time-dependent manner (Fig. 4.2.7C, D, G, and H). As a result, the 
induction of Ppm1d transcription is dependent on wild-type p53 when cells are 
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challenged with low-dose UV radiation. However, the suppression of Ppm1d 
transcription is independent of wild-type p53 when cell are stimulated with high-dose 
UV radiation. The suppression of Wip1 protein level upon high-dose UV may 
partially result from the transcriptional suppression of Ppm1d gene. 




Figure 4.7 The transcription of Ppm1d gene in response to different doses of UV 
radiation in the presence or absence of p53. U2OS (A, B, C, D) and Saos2 (E, F, G, H) 
cells were cultured for 36 hr before UV treatment. Culture medium was removed before UV 
treatment. Cells were subjected to 5 J/m2 (A, B, E, F) and 50 J/m2 (C, D, G, H) UV. After UV 
radiation, cells were recovered in culture medium, and harvested at different time points as 
indicated in the figure. The expression levels of Ppm1d gene were assessed using real-time 
PCR with two sets of primers targeting different regions of Ppm1d gene. GADPH was used 





Wip1 Regulation in UV 
122 
4.2.8 The Wip1 protein level is under post-translational regulation in response to 
high-dose UV radiation 
 We have noticed that Wip1 protein level started to decrease instantaneously upon 
high-dose UV radiation. Although the transcription of Ppm1d gene was suppressed as 
soon as the cells were challenged with high-dose UV, post-translational regulation of 
Wip1 protein may also be involved in the decrease of Wip1 protein level. Therefore, 
we examined the effects of both low- and high-dose UV radiation on the exogenous 
Wip1 protein level in HCT116 p53 KO cells in the presence of cycloheximide (CHX), 
which inhibits de nevo protein synthesis. p3XFlag Wip1 vector was over-expressed in 
HCT116 p53 KO cells. As shown in Fig. 4.8A, Flag-Wip1 protein level was not 
changed by 5 J/m2 UV radiation at the 4 hr time point in the presence of CHX. 
However, Flag-Wip1 protein level was profoundly decreased in response to 50 J/m2 
UV radiation in the presence of CHX (Fig. 4.8A). These results suggest that 
post-translational regulation is involved in high-dose UV-mediated suppression of 
Wip1 protein level, probably via p53-independent machinery. In mammalian cells, the 
proteasome-mediated protein degradation regulates the turnover of a wide range of 
proteins. We therefore utilized MG132 to inhibit the proteasome-mediated protein 
degradation in MCF-7 cells, which were then stimulated with 50 J/m2 UV. In the 
presence of MG132, Wip1 protein level was fully rescued (Fig. 4.8B). We speculate 
that the post-translational regulation also plays an important role in reducing Wip1 
protein level upon high-dose UV radiation. Moreover, Wip1 protein level might be 
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regulated via proteasome-mediated degradation pathway. 




Figure 4.8 High-dose UV-induced post-translational regulation of 
Wip1 protein. (A) p3XFlag Wip1 vector was over-expressed in HCT116 
p53 KO cells. 24 hr after transfection, the cells were subjected to 
treatments as indicated in the figure. Proteins were extracted, separated on 
SDS-PAGE, and probed with anti-Flag antibody. α-Tubulin was used as a 
protein loading control. (B) MCF-7 cells were cultured for 36 hr before 
treatment. Cells were subjected to treatments as indicated in the figure. 
Proteins were extracted, separated on SDS-PAGE, and probed with 
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4.2.9 The non-conserved C-terminal is important for Wip1 degradation 
 Wip1 belongs to the protein phosphatase type 2C family. The conserved PP2C 
phosphatase domain is located in the N-terminal of Wip1 protein (Fig. 2.2). In order to 
investigate how Wip1 is post-translationally regulated, we generated different 
fragments containing different domains of Wip1 protein and examined the stability of 
these fragments. p3XFlag Wip1, p3XFlag DN, p3XFlag FC, and p3XFlag FN were 
separately over-expressed in HEK293T cells. At 24 hr after transfection, CHX was 
applied to the transfected cells and then the cells were harvested at different time 
points. As shown in Fig. 4.9A, Flag-Wip1 DN and Flag-Wip1 FC were almost totally 
degraded within 2 hr after CHX treatment. The full-length Wip1 was degraded in a 
time-dependent manner within 8 hours after the addition of CHX (Fig. 4.9A). Unlike 
other fragments, the Flag-Wip1 FN was very stable within 8 hr after CHX treatment 
(Fig. 4.9A). Due to the relatively shorter half-life of Flag-Wip1 DN and Flag-Wip1 
FC fragments, we further compared the stability of these two fragments within shorter 
time period. As shown in Fig. 4.9B, Flag-Wip1 FC degraded faster than Flag-Wip1 
DN within 2 hr after CHX treatment. These results indicate that the C-terminal 
domain of Wip1 may be critical in regulating its destruction. On the contrary, the first 
60 amino acids located in the N-terminal may have certain function in stabilizing 
Wip1.  
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Figure 4.9 Stability assay of full-length Wip1 and Wip1 fragments. (A) and (B) 
p3XFlag Wip1, p3XFlag DN, p3XFlag FC, and p3XFlag FN were seperately 
over-expressed in HEK293T cells. 24 hr after transfection, cells were subjected to 100 
μg/ml CHX treatment. Cells were harvested at different time points as indicated in the 
figure. Proteins were extracted, separated on SDS-PAGE, and probed with anti-Flag 
antibody. GADPH was used as a protein loading control.  
A 
B 
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4.3 Discussion 
 DNA damage stimulates a series of cellular responses including cell cycle arrest, 
DNA repair, and apoptosis. The cellular responses are delicately coordinated so as to 
minimize the damage to the cells and to maintain the genomic integrity of the cells. 
The cells harboring DNA damage launched apoptosis when the damaged DNA is not 
properly repaired or the cell cycle arrest is not successfully bypassed. However, how 
and when the cells make a decision to launch apoptosis is barely understood. 
UV-induced DNA damage stimulates different cellular responses depending on the 
doses of UV insult. As a central coordinator of UV-induced DNA damage responses, 
p53 performs differently upon different doses of UV radiation (Cotton and Spandau, 
1997; Reinke and Lozano, 1997; Wu and Levine, 1997; Latonen et al., 2001). Wip1 
phosphatase acts both as a downstream target and an upstream regulator of p53 
(Fiscella et al., 1997; Takekawa et al., 2000; Lu et al., 2005). Moreover, Wip1 plays 
important roles in relieving cells from DNA damage-induced cell cycle checkpoints 
(Lu et al., 2005; Fujimoto et al., 2006). Therefore, Wip1 may have different 
performances in response to different doses of UV radiation. 
 Our preliminary results in this section discovered different behaviors of Wip1 
protein in response to different doses of UV radiation (Fig. 4.1). Wip1 protein level 
increases or decreases upon low-dose and high-dose UV radiation, respectively (Fig. 
4.2). Moreover, the low-dose UV transiently induces Wip1 protein level; whereas the 
high-dose UV mediates a persistent suppression of Wip1 protein level (Fig. 4.2). The 
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induction of Wip1 protein level is accompanied with S phase arrest, while the 
suppression of Wip1 protein level is accompanied with apoptosis (Fig. 4.3). 
Importantly, the suppression of Wip1 protein level is not a consequence of high-dose 
UV-induced apoptosis (Fig. 4.4). The DNA damage pathway also displays different 
responses to different doses of UV radiation (Fig. 4.5). The transcription of Ppm1d 
gene is induced by low-dose UV radiation in a p53-dependent manner (Fig. 4.6 and 
Fig. 4.7). On the contrary, the transcription of Ppm1d gene is suppressed by high-dose 
UV radiation in a p53-independent manner (Fig. 4.6 and Fig. 4.7). Upon high-dose 
UV radiation, Wip1 protein level is also under post-translational regulation in a 
p53-independent manner by unknown signaling pathways (Fig. 4.8). Our current 
results also suggest that the non-conserved C-terminal of Wip1 may be important in 
controlling its degradation (Fig. 4.9). 
 Previous studies have found that Wip1 protein level is induced by many different 
kinds of DNA damage agents in a p53-dependent manner (Fiscella et al., 1997; 
Takekawa et al., 2000). Recently, a p53-response element has been identified at the 
5’-UTR of Ppm1d gene (Rossi et al., 2008). According to our observations, in 
response to high-dose UV radiation, Wip1 protein level is suppressed via both 
transcriptional and post-translational regulations. Two important questions have not 
been fully addressed regarding the regulation of Wip1 protein level: (1) What is the 
upstream signal that decides whether Wip1 protein should accumulate or decrease 
upon different doses of UV radiation? (2) How is Wip1 protein level down-regulated 
upon high-dose UV radiation? 
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Both low- and high-dose UV radiation induce the accumulation of p53 protein in 
the early stage of cellular response. p53 protein level decreases in the late stage after 
low-dose UV radiation, whereas p53 protein level sustains in the late stage after 
high-dose UV radiation. However, at very early stage after UV insult, the destiny of 
Wip1 protein has already been decided. Therefore, p53 may not act as the decisive 
signal for the destiny of Wip1 protein. On the contrary, the different behaviors of 
Wip1 protein upon different doses of UV radiation may affect the phosphorylation 
and transcription activity of p53. The events, which decide the destiny of Wip1 
protein, might happen even at the upstream of p53 in the DNA damage signaling upon 
UV radiation. In mammalian cells, ATR is the upstream most sensor protein of 
UV-induced replication block (Durocher and Jackson, 2001; Shiloh, 2001). In the 
initial stage of DNA damage signaling, the ssDNA-RPA complex generated at the 
replication block site recruits ATR-ATRIP and Rad17 to load 911 complex (Zou and 
Elledge, 2003; Byun et al., 2005; Yang and Zou, 2006). On one hand, ATR 
phospohorylates Rad17, 911 complex, and TopBP1. On the other hand, these proteins 
mutually stimulate ATR kniase activity (Majka et al., 2006; Yang and Zou, 2006). The 
activated ATR proceeds to phosphorylate other substrates, including Chk1 and p53 
(Harper and Elledge, 2007). The ATR-mediated signaling might be involved in 
determining whether Wip1 should accumulate or decrease upon different doses of UV 
radiation. Therefore, the behavior of these proteins can be examined under different 
doses of UV insult. To investigate this, we will block the ATR signaling with the 
ATM/ATR inhibitor (cell permeable thiourea, or caffeine). If the blockade of ATR 
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signaling abolishes high-dose UV-mediated suppression of Wip1, we will trace the 
downstream of ATR to dig up possible regulators of Wip1. To do this, 
siRNA-mediated knock-down of ATR downstream proteins will be performed to 
identify the direct regulators of Wip1. 
It has been well studied that the induction of Wip1 upon DNA damage is 
dependent on p53-mediated transcription (Fiscella et al., 1997; Takekawa et al., 2000). 
Our results suggest that the high-dose UV-mediated decrease of Wip1 protein may be 
under both transcriptional and post-translational regulations. The most extensively 
studied transcription factors upon UV radiation are p53, NF-κB and AP-1 (Latonen 
and Laiho, 2005). However, our results have already suggested that the transcriptional 
suppression of Ppm1d gene is not dependent on wild-type p53. However, at the 
current stage, we cannot rule out the possibility that, in response to high-dose UV 
radiation, the transcription of Ppm1d gene is regulated by additional transcription 
regulators. It has been reported recently that the basal expression of Ppm1d gene is 
regulated by CREB (Rossi et al., 2008). In MCF-7 cells, high-dose UV radiation but 
not low-dose UV radiation stimulates phosphorylation of CREB on Ser133 residue 
(Fig. 4.5). The Ppm1d promoter containing the cAMP response element can be 
isolated for activity assay upon different doses of UV radiation, so as to examine the 
possible role of CREB in regulating UV-mediated Ppm1d transcription. We also 
cannot rule out the possibility that UV radiation mediates transcriptional suppression 
of some genes by directly disrupting mRNAs (Roos and Kaina, 2006). The decrease 
of Ppm1d transcription may be a direct and general effect of UV-induced transcription 
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suppression. 
 According to our current results, high-dose UV also suppresses Wip1 protein 
level via post-translational machinery (Fig. 4.8). The proteasome-mediated protein 
degradation pathway may be involved in the suppression of Wip1 protein level. 
However, whether proteasome is directly or indirectly involved in Wip1 degradation 
is not yet clear. Moreover, MG132 might inhibit the degradation of other proteins, 
which may have a role in stabilizing Wip1. The ubiquitin assay should be performed 
to identify if Wip1 can be directly poly-ubiquitinated and targeted to the 
proteasome-mediated degradation. We should also examine if high-dose UV 
stimulates poly-ubiuqitination of Wip1 protein. The analysis of Wip1 domain stability 
suggests that the C-terminal may be essential for the degradation of Wip1. Therefore, 
the N-terminal of Wip1 may be more stable than the full-length Wip1 protein upon 
high-dose UV stimulation. Because the conserved PP2C domain is located in the 
N-terminal of Wip1, over-expression of the Wip1 N-terminal fragment may interfere 
with the apoptotic response upon high-dose UV radiation.  
 In summary, our current results show that Wip1 protein is differentially regulated 
in response to different doses of UV radiation. Moreover, the different performances 
of Wip1 protein correlate with specific cellular responses upon UV radiation. 
Ascribing to the important roles of Wip1 in DNA damage response, further 
experiments need to be done to fully illustrate the underlying mechanisms of such 
delicate regulation. 
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Chapter 5 General Discussion and Conclusion 
 Tumourigenesis is a complex and multistep process, in which many signaling 
pathways are involved. Aberrant cell cycle checkpoints and deregulated apoptosis are 
two important characteristics of cancers. Wip1 phosphatase is an important regulator 
of several components in DNA damage pathway. Moreover, up-regulation of Wip1 
has been found in many different types of human cancers. Previous studies have 
established that Wip1 is an important coordinator of cell cycle checkpoints after DNA 
damage insult (Lu et al., 2008). In response to DNA damage, Wip1 relieves the 
damaged cells from cell cycle arrest after DNA repair is completed. 
 It has been reported that Wip1 negatively regulates apoptosis in response to DNA 
damage insult. The phosphorylation of p38, p53 and Chk2 are inhibited by Wip1 after 
DNA damage, resulting in reduced apoptotic response (Takekawa et al., 2000; Lu et 
al., 2005; Fujimoto et al., 2006). Our studies discovered that Wip1 not only regulates 
DNA damage-induced apoptosis but also regulates apoptosis induced by other 
environmental stresses. Wip1 negatively regulates ribotoxic stress-induced apoptosis 
by inhibiting both p38 and JNK MAPK pathways. By selectively dephosphorylating 
the Thr261 residue of MKK4, Wip1 inhibits the kinase activity of MKK4, and 
subsequently the activation of JNK-c-Jun signaling. As a result, the transcription of 
FasL is inhibited, leading to suppression of extrinsic pathway-mediated apoptosis. 
Moreover, Wip1 may act as a general mediator of apoptosis in response to a wide 
range of environmental stresses. Although Wip1 suppresses ribotoxic stress-induced 
apoptosis mainly via dephosphorylation and inhibition of MKK4, Wip1 may also be 
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involved in regulating other components of stress-induced apoptotic signaling. In 
addition, Wip1 may regulate the apoptotic pathway indirectly via p53 downstream 
genes, because Wip1 acts as an inhibitor of p53 transcription activity. 
 In response to DNA damage, Wip1 might regulate apoptosis mainly via 
mediating the phosphorylation of the components in DNA damage pathway, including 
p53, p38 and Chk2. However, in response to ribotoxic stress, Wip1 selectively 
regulates the phosphorylation and activity of p38 and JNK, thereby affecting 
apoptotic response. We speculate that, stimulated by different kinds of environmental 
stresses, Wip1 is able to selectively mediate the activity of different pathways 
targeting apoptosis. Suppression of both p38 and JNK pathways successfully reverses 
anisomycin-induced apoptotic response in Wip1-/- MEFs. However, suppression of 
both p38 and JNK pathways cannot reverse etoposide-induced apoptotic response in 
Wip1-/- MEFs. Hence, Wip1 plays diverse roles in regulating the apoptotic responses 
upon a variety of environmental stresses. 
 UV radiation-induced DNA damage stimulates a series of cellular responses, 
including cell cycle arrest, DNA repair, and apoptosis. Wip1 plays important roles in 
regulating both cell cycle checkpoints and apoptosis. As an important DNA damage 
agent, low-dose UV stimulates transient cell cycle arrest, while high-dose UV causes 
apoptosis (Latonen and Laiho, 2005). We found that Wip1 performs differently in 
response to different doses of UV radiation. In response to low-dose UV radiation, 
Wip1 protein level increases accompanied with cell cycle arrest. However, in 
response to high-dose UV radiation, Wip1 protein level decreases accompanied with 
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apoptotic cell death.  
The transcription of Ppm1d gene is up-regulated by low-dose UV radiation in a 
p53-dependent manner. However, the suppression of Wip1 protein level upon 
high-dose UV radiation is regulated via both transcriptional and post-translational 
machineries in a p53-independent manner. The suppression of Ppm1d transcription 
upon high-dose UV radiation might be regulated by transcription factors other than 
p53. We also cannot exclude the possibility that the transcriptional suppression of 
Ppm1d is directly result from high-dose UV-induced transcription stress. So far, little 
has been reported regarding the post-translational regulation of Wip1 in response to 
DNA damage insult. Our results suggest that the stability of Wip1 may be regulated 
by the proteasome-mediated degradation machinery. Moreover, suppression of 
proteasome activity can reverse the high-dose UV-mediated degradation of Wip1. 
Therefore, Wip1 protein level is under multiple and complex regulations in response 
to different doses of UV radiation. We will further investigate whether Wip1 is 
directly or indirectly degraded via the ubiquitin-proteasome system, and how Wip1 is 
targeted to degradation.  
 Although the involvement of Wip1 in tumourigenesis has been intensively 
studied, the underlying mechanism is not yet fully understood. Wip1 regulates two 
important facets of tumourigenesis: cell cycle checkpoints and apoptosis. 
Up-regulation of Wip1 protein and amplification of Ppm1d gene have been 
discovered in many human cancers (Li et al., 2002; Hirasawa et al., 2003; Saito-Ohara 
et al., 2003). Different doses of UV radiation stimulate different cellular responses. 
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Combined with the fact that Wip1 protein level is differentially regulated upon 
different doses of UV radiation, the protein level of Wip1 is tightly associated with the 
cell fate. Inhibition of Wip1 protein may be helpful in introducing cancer cells to 
stress-induced apoptosis. Moreover, the protein level of Wip1 may act as an indicator 
of the cellular susceptibility to apoptotic stimuli. However, little is known about the 
decisive signals leading to different destinies of Wip1 protein. Further investigation is 
required to determine whether Wip1 is the sensor of cell fate, or is the operator of the 
cell fate. Our current and ongoing studies should improve our understanding of the 
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Chapter 6 Appendices 
6.1 Wip1 is implicated cell motility regulation 
In all multi-cellular organisms, cell migration is an essential process, which plays 
important roles during development, wound repair and immune surveillance 
(Vicente-Manzanares et al., 2005). Cell migration also occurs in chronic human 
diseases, such as tumourigenesis (Yamaguchi et al., 2005). The two well-recognized 
defining hallmarks of cancer are uncontrolled proliferation and invasion. The loss of 
control on cell proliferation represents the initiating phase of tumourigenesis that 
leads to the establishment of primary tumor. The most critical modification during 
tumourigenesis is the conversion of a static primary tumor into an invasive 
disseminating metastasis. The cancer cells possess higher mobility in response to cues 
from the microenvironment. Therefore, molecules involved in cancer cell migration 
could be potential targets for anti-metastasis therapy. 
 The oncogenic PP2C phosphatase Wip1 regulates the DNA damage pathway by 
dephosphorylating a series of proteins involved in DNA damage response. Among 
these substrates, p53 and p38 play multiple roles in many different cellular pathways. 
The traditional functions of p53 include cell cycle regulation, apoptosis and DNA 
repair. Moreover, many p53 downstream genes are involved in regulating cell 
adhesion, cell migration, and cytoskeleton organization, such as keratin, fibronectin, 
and VEGF. The wild-type p53 prevents filopodia formation, inhibits cell spreading 
and polarization. Consistently, the p53-deficient cells display increased mobility 
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(Roger et al., 2006). More importantly, the mouse with inactive p53 has a dramatically 
accelerated invasiveness. Apart from p53, p38 MAPK is also involved in growth 
factor- and cytokine-induced cell migration (Huang et al., 2004). Given these 
observations, we speculate that Wip1 may play certain role in regulating cell 
migration. 
6.1.1 Wip1 acts as a positive regulator of cell migration 
In order to test if the mobility of the fibroblasts is regulated by Wip1, wild-type 
and Wip1-/- MEFs were subjected to the wound-healing assay. The wound-healing 
assay is a simple method to study directional cell migration in vitro. This method is 
based on the observation of cell migration into a “wound” created on a cell monolayer. 
The wild-type and Wip1-/- MEFs were grown to 70% confluence in the 0.2% 
gelatin-coated 6-well plates. Before wounding, both wild-type and Wip1-/- MEFs 
were subjected to 0% FBS starvation for 24 hr. After wounding, MEFs were allowed 
to migrate for 15 hr in different culture conditions as indicated in Fig. 6.1.  
 The Wip1-/- MEFs exhibited a significantly reduced motility compared to the 
wild-type MEFs in the presence or absence of the indicated growth factors. Although 
EGF and PDGF treatments stimulated the mobility of both wild-type and Wip1-/- 
MEFs, the wild-type MEFs were more sensitive to growth factor stimulation. The 
wild-type MEFs filled up the wound thoroughly 15 hr after wounding when 
stimulated with 20 ng/ml PDGF. However, Wip1-/- MEFs displayed defective mobility, 
and were not able to fill up the wound 15 hr after wounding (Fig. 6.1). Therefore, it is 
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Figure 6.1 Assessment of wild-type and Wip1-/- MEFs mobility in 
wound-healing assay. The wild-type and Wip1-/- MEFs were seeded in 0.2% 
gelatin-coated 6-well plates, and cultured to 70% confluence. MEFs were subjected 
to 0% FBS starvation for 24 hr. The wounds were created with yellow tips. After 
wounding, MEFs were cultured as indicated in the figure. Pictures were taken 15 hr 
after wounding. The results were representatives of three independent experiments. 
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6.1.2. Loss of Wip1 impairs growth factor-induced cell motility 
In order to further confirm the results obtained from wound-healing assay, we 
proceeded to perform the Boyden chamber assay (Costar), which is ideally suited for 
the quantitative analysis of cell chemotaxis. The mobility of wild-type and Wip1-/- 
MEFs in response to different stimuli was tested by Boyden chamber assay, as shown 
in Fig. 6.2. Briefly, wild-type and Wip1-/- MEFs grown to 70% confluence were 
subjected to 0% FBS starvation for 24 hr. After starvation, 5 × 104 of wild-type and 
Wip1-/- MEFs were seeded in the upper chamber. The MEFs were allowed to migrate 
from the upper chamber to the lower chamber for 4 hr. The migrated cells were fixed 
with 4% paraformaldehyde, and visualized by Giemsa (Sigma). For each chamber, 5 
different areas were randomly selected and photographed (10× object lense), and the 
migrated cells were counted. The data shown were the average of three independent 
experiments, and the error bars represented standard deviation.  
 As shown in Fig. 6.2A, more wild-type MEFs migrated from the upper chamber 
to the lower chamber than Wip1-/- MEFs in the absence and presence of different 
growth factors. Among 4 different kinds of growth factors, PDGF was the most potent 
in inducing cell mobility. EGF and FGF both induced cell mobility, although the 
effects were not as significant as PDGF. VEGF displayed a minor effect in inducing 
mobility of both wild-type and Wip1-/- MEFs. In Fig. 6.2B-F, the migrated cell 
number of Wip1-/- MEFs was compared to that of wild-type MEFs, the migrated cell 
number of which was considered to be 100%. Fig. 6.2D showed that PDGF treatment 
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relatively enhanced the mobility of Wip1-/- MEFs compared to the wild-type MEFs. 
There results suggest that the mobility of Wip1-/- MEFs is dramatically impaired. In 
addition, PDGF-mediated signaling pathway may have certain crosstalk with 





B C D 
E F 
Figure 6.2 Impaired mobility of Wip1-/- MEFs in the absence and presence of 
different kinds of growth factors. (A) The wild-type and Wip1-/- MEFs were 
subjected to Boyden Chamber Assay in the absence and presence of different growth 
factors as indicated in the figures. The data were expressed as the mean + S.D. from 
three independent experiments. (B-F) The migrated cell number of Wip1-/- MEFs was 
compared to that of wild-type MEFs, the migrated cell number of which is considered 




6.1.3. Wip1-deficient MEFs have more actin stress fibers and focal adhesions  
Cell migration involves dynamically and spatially regulated changes of the 
cytoskeleton and cell adhesions. In order to examine the factors responsible for the 
defective mobility of Wip1-/- MEFs, actin cytoskeleton and focal adhesions of MEFs 
were visualized by immunostaining with phalloidin (Molecular Probe) and paxillin 
antibody (Santa Cruz), respectively. As shown in Fig. 6.3, wild-type MEFs had fewer 
actin stress fibers than Wip1-/- MEFs when cultured in DMEM containing 10% FBS. 
Serum starvation significantly induced actin stress fibers in wild-type MEFs; whereas 
it had marginal effect on the number of actin stress fibers in Wip1-/- MEFs. These 
results indicate that Wip1-/- MEFs had a higher endogenous level of actin stress fibers 
than the wild-type MEFs. Both the MEFs were subjected to 0% FBS starvation for 48 
hr before growth factor treatments. In Wip1-/- MEFs, EGF treatment slightly reduced 
the number of actin stress fibers. In wild-type MEFs, the actin stress fibers, which 
were induced by serum starvation, decreased dramatically upon EGF treatment (Fig. 
6.3). Compared to EGF treatment, PDGF treatment greatly decreased the number of 
actin stress fibers both in wild-type and Wip1-/- MEFs (Fig. 6.3). This phenomenon 
may explain the reason why PDGF enhanced the relative mobility of Wip1-/- MEFs 
compared to the wild-type MEFs. However, Wip1-/- MEFs still retained more actin 
stress fibers than the wild-type counterpart upon PDGF treatment, in agreement with 
the partially impaired mobility of Wip1-/- MEFs in the presence of PDGF.   
Focal adhesions displayed a similar pattern as actin stress fibers in the wild-type 
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and Wip1-/- MEFs (Fig. 6.4). The wild-type MEFs contained fewer focal adhesions 
than that in Wip1-/- MEFs, when cultured in DMEM containing 10% FBS. Moreover, 
the focal adhesions surrounded the periphery of whole cell body of Wip1-/- MEFs. 
Serum starvation increased the number of focal adhesions significantly in the 
wild-type MEFs (Fig. 6.4). However, the number of focal adhesions did not change 
greatly in response to serum starvation in Wip1-/- MEFs due to relatively higher 
endogenous level of focal adhesions (Fig. 6.4). In response to EGF stimulation, the 
number of focal adhesions in the wild-type MEFs decreased dramatically (Fig. 6.4). 
However, in Wip1-/- MEFs, the number of focal adhesions was not decreased upon 
EGF treatment (Fig. 6.4). PDGF treatment decreased the number of focal adhesions 
profoundly both in wild-type and Wip1-/- MEFs, though Wip1-/- MEFs reserved a few 
number of focal adhesions. These results attribute the defective mobility of Wip1-/- 




Figure 6.3 Visualization of actin stress fibers in wild-type and Wip1-/- MEFs. The 
wild-type and Wip1-/- MEFs were cultured on 0.2% gelatin-coated 18mm coverslips. MEFs 
were treated as indicated in the figures, and fixed with 4% paraformaldehyde. The actin 






Figure 6.4 Visualization of focal adhesions in wild-type and Wip1-/- MEFs. The 
wild-type and Wip1-/- MEFs were cultured on 0.2% gelatin-coated 18mm 
coverslips. MEFs were treated as indicated in the figures, and fixed with 4% 
paraformaldehyde. The focal adhesions were visualized with anti-Paxillin primary 




6.1.4. Wip1 regulates cell motility via RhoA  
It has been established that Rho family GTPases play important roles in 
regulating cell migration. Three subfamilies of Rho proteins including Rac-like, 
Cdc42-like, and Rho-like proteins have been extensively studied. Rac-like proteins 
regulate the formation of lamellipodia and membrane ruffles. Cdc42-like GTPases are 
implicated in mediating the formation of filopodia. The Rho-like proteins contribute 
to the formation of actin stress fibers and focal adhesions (Ridley, 2001). In the 
Rho-like subfamily, RhoA plays important roles in regulating cytoskeleton and 
cell-matrix adhesion (Hall, 1998). In order to investigate if the RhoA-related pathway 
is defective in Wip1-/- MEFs, we examined RhoA protein level in the wild-type and 
Wip1-/- MEFs. As shown in Fig. 6.5A, Wip1-/- MEFs contained a higher basal level of 
RhoA than the wild-type MEFs. The profound RhoA protein level in Wip1-/- MEFs 
may contribute to the higher endogenous levels of actin stress fibers and focal 
adhesions.  
The dynamics of RhoA protein was examined in the process of serum starvation 
and growth factor treatment. As shown in Fig. 6.5B, in the wild-type MEFs, RhoA 
protein level was up-regulated dramatically in response to serum starvation. However, 
RhoA protein level was slightly increased upon serum starvation in Wip1-/- MEFs (Fig. 
6.5B). After 48 hr serum starvation, MEFs were subjected to EGF treatment. In the 
wild-type MEFs, RhoA protein level gradually decreased upon EGF treatment (Fig. 
6.5B). However, in Wip1-/- MEFs, RhoA protein level did not decrease in response to 
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EGF treatment (Fig. 6.5B). The results shown here indicate that Wip1 may regulate 






Figure 6.5 Enhanced RhoA protein levels in Wip1-/- MEFs. (A) The wild-type and 
Wip1-/- MEFs were cultured to 70% confluence. The proteins were extracted, separated on 
SDS-PAGE, and probed with anti-RhoA antibody. α-Tubulin was used as a protein loading 
control. (B) The wild-type and Wip1-/- MEFs were cultured to 70% confluence, and 
subjected to the treatment as indicated in the figure. The proteins were extracted, separated 





6.2 In vitro phosphatase activity 
6.2.1 Preparation of recombinant GST-Wip1 and GST-Wip1 FN beads 
BL21 strains transformed with pGEX-4T-1 Wip1, pGEX-4T-1 FN or 
pGEX-4T-1 were cultured to OD600 > 0.8 and induced with 0.4 mM IPTG for 3 hr at 
37ºC. After induction, the cultures were lysed and incubated with GST beads for 3 hr 
at 4ºC. As shown in Fig. 6.6A, both GST-Wip1 and GST-Wip1 FN were successfully 
induced by IPTG and captured by GST beads. However, GST-Wip1 protein was much 








Figure 6.6 Induction of recombinant GST-Wip1 and GST-Wip1 FN proteins. (A) and 
(B) BL21 strains transformed with pGEX-4T-1 Wip1, pGEX-4T-1 FN or pGEX-4T-1 
were subjected to 0.4 mM IPTG induction for 3 hr at 37ºC. The cultures were lysed and 
captured by GST beads for 3 hr at 4ºC. Samples were loaded to SDS-PAGE as indicated in 
the figure. After electrophoresis, the gels were subjected to commassie blue staining to 
visualize protein bands. 
M: Marker 
A1: GST-Wip1 before IPTG induction 
A2: GST-Wip1 after IPTG induction 
A3: GST-Wip1 beads 
A4: GST-Wip1 FN before IPTG induction 
A5: GST-Wip1 FN after IPTG induction 
A6: GST-Wip1 FN beads 
M: Marker 
B1: GST before IPTG induction 
B2: GST after IPTG induction 
B3: GST beads 
B4: GST-Wip1 before IPTG induction 
B5: GST-Wip1 after IPTG induction 
B6: GST-Wip1 beads 
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6.2.2 The purification of GST-Wip1 and GST-Wip1 FN proteins from GST beads 
GST-Wip1 and GST-Wip1 FN beads were either subjected to thrombin cleavage 
or eluted with reduced L-glutathione. After thrombin cleavage or elution with reduced 
L-glutathione, the supernatants were concentrated to less than 500 μl volume. Both 
the supernatants and the remaining beads were subjected to SDS-PAGE. As shown in 
Fig. 6.7A, thrombin cleavage of GST-Wip1 and GST-Wip1 FN generated very low 
yield of Wip1 and Wip1 FN proteins, respectively. However, GST-Wip1 and 
GST-Wip1 FN proteins were eluted from GST beads efficiently with reduced 
L-glutathione (Fig. 6.7A). GST was also eluted from GST beads by reduced 





Figure 6.7 Purification of recombinant proteins. (A) and (B) GST-Wip1, GST-Wip1 FN 
and GST beads were subjected to treatment as indicated in the figure. Samples were loaded 
to SDS-PAGE as indicated in the figure. After electrophoresis, the gels were subjected to 
commassie blue staining to visualize protein bands. 
M: Marker 
A1/A2: GST-Wip1 beads/elution after reduced 
L-glutathione incubation 
A3/A4: GST-Wip1 beads/elution after thrombin 
cleavage 
A5/A6: GST-Wip1 FN beads/elution after 
reduced L-glutathione incubation 
A7/A8: GST-Wip1 FN beads/elution after 
thrombin cleavage 
M: Marker 
B1/B2: GST beads/elution after reduced 
L-glutathione incubation 






6.2.3 The assessment of phosphatase activity of recombinant GST-Wip1 or 
GST-Wip1 FN proteins 
The GST-Wip1 and GST-Wip1 FN proteins were used for the in vitro 
phosphatase assay. pXJ-40-Flag MKK4 and pXJ-40-Flag p38 constructs were 
over-expressed in HEK293T cells. 24 hr after transfection, the HEK293T cells were 
stimulated with 10 μM anisomycin for 2hr. After anisomycin stimulation, cells were 
lysed with mammalian cell lysis buffer and subjected to immunoprecipitation with 
Flag M2 affinity gel for 2 hr at 4ºC. After immunoprecipitation, Flag M2 affinity gel 
was washed with mammalian cell lysis buffer for 5 times and used as substrate for in 
vitro phosphatase assay. A phospho-peptide, RRA(pT)VA, was provided by the 
phosphatase kit (Progema) and used as a positive substrate of PP2C phosphatases. Fig. 
6.8 showed that both GST-Wip1 and GST-Wip1 FN were not able to dephosphorylate 
phospho-MKK4, phospho-p38 and the phospho-peptide positive control. These 
results indicate that the recombinant GST-Wip1 and GST-Wip1 FN protein may lack 






Figure 6.8 Phosphatase assay with recombinant GST-Wip1 or GST-Wip1 FN 
proteins. GST-Wip1 (A) and GST-FN (B) were purified and subjected to in vitro 
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